Table Of Content

European Journal of Pharmacology, 231 (1993) 489-492 © 1993 Elsevier Science Publishers B.V. All rights reserved 0014-2999 /93 /$06.00 Author index Al-Zubaidy, Z., see Chapman, A.G. (231) 301 Chaouloff, F., see Baudrie, V. (231) 395 Antunes, E., see Santana, A.C. (231) 237 Chapman, A.G., Al-Zubaidy, Z. and Meldrum, B.S Arimura, A., Asanuma, F., Yagi, H., Kurosawa, A. and Harada, M Aniracetam reverses the anticonvulsant action of NBOX and Involvement of thromboxane A, in bronchial hyperresponsive GYKI 52466 in DBA/2 mice (231) 301 ness but not lung inflammation induced by bacterial lipopolysac Chase, T.N., see Marin, C. (231) 191 charide in guinea pigs (231) 13 Chiba, S., see Takayama, S. (231) 315 Arora, R.C., see Gulati, A. (231) 151 Choppin, A. and O'Connor, S.E. Asanuma, F., see Arimura, A. (231) 13 Pre-contraction with histamine and U46619 unmasks a 5-HT,-like receptor in rabbit renal artery (231) 469 Bai, X., see Walker, J.M. (231) 61 Chovet, M., see Pascaud, X.B. (231) 389 Bakhle, Y.S., see Santana, A.C. (231) 237 Chulia, S., see Ivorra, M.D. (231) 165 Barnes, P.J., see Belvisi, M.G. (231) 97 Chung, K.F., see Sakamoto, T. (231) 31 Barnes, P.J., see Rabe, K.F. (231) 305 Cools, A.R., see Prinssen, E.P.M. (231) 275 Barnes, P.J., see Sakamoto, T. (231) 31 Crayton, J., see Gulati, A. (231) 151 Baudrie, V., De Vry, J., Broqua, P., Schmidt, B., Chaouloff, F. and Glaser, T Damas, J., Remacle-Volon, G. and Bourdon, \ Subchronic treatment with anxiolytic doses of the 5-HT,, recep Platelet-activating factor and the vascular effects of zymosan in tor agonist ipsapirone does not affect 5-HT, receptor sensitivity rats (231) 231 in the rat (231) 395 DeHaven-Hudkins, D.L., see Hudkins, R.L. (231) 485 Baudrie, V., see Chaouloff, F. (231) 77 Del Bianco, E., see Santicioli, P. (231) 139 Bélichard, P., see Pruneau, D. (231) 215 Dent, G., see Rabe, K.F. (231) 305 Belvisi, M.G., Miura, M., Stretton, D. and Barnes, PJ De Nucci, G., see Santana, A.C. (231) 237 Endogenous vasoactive intestinal peptide and nitric oxide modu Dessy, C., Salomone, S., Morel, N. and Godfraind, T late cholinergic neurotransmission in guinea-pig trachea (231) 97 Activity of dihydrothienopyridine $312 enantiomers on L-type Berzetei-Gurske, I.P., see Webster, J.L. (231) 251 Ca** channels in isolated rat aorta and cerebral microvessels Bloss, J.L., see Hammond, D.L. (231) 281 (231) 435 Bond, A., see Boot, J.R. (231) 83 De Vry, J., see Baudrie, V. (231) 395 Boot, J.R., Bond, A., Thomas, K.H., O’Brien, A., Gilmore, J. and Diana, M., see Rossetti, Z.L. (231) 203 Todd, A Divish, B.J., see Pollock, D.M. (231) 459 The pharmacology of LY290324 in the guinea-pig: an orally D’Ocon, M.P., see Ivorra, M.D. (231) 165 active, potent and selective cysteiny! leukotriene receptor antago Dolata, J., see Lindberg, S. (231) 375 nist (231) 83 Dutar, P., see Potier, B. (231) 427 Bot, G. and Chahl, L.A Effects of pertussis toxin on behavioural responses of guinea-pigs Ellenbroek, B.A., see Prinssen, E.P.M. (231) 275 to centrally administered substance P, quinpirole, carbachol, | Evans, P., see Rabe, K.F. (231) 305 50,488H, morphine and morphine withdrawal (231) 53 Bourdon, V., see Damas, J. (231) 231 Fedele, E., see Pittaluga, A. (231) 129 Bowen, W.D., see Walker, J.M. (231) 61 Ferrer, J.M.R., Sabater, R. and Saez, J.A Brandt, S.R., see Webster, J.L. (231) 251 Neurotensin participates in self-stimulation of the medial pre Brédemann, R., see Krug, M. (231) 355 frontal cortex in the rat (231) 39 Broqua, P., see Baudrie, V. (231) 395 Frew, R., see Lundy, P.M. (231) 197 Burres, N.S., see Pollock, D.M. (231) 459 Fride, E. and Mechoulam, R Pharmacological activity of the cannabinoid receptor agonist, Calignano, A., Persico, P., Mancuso, F. and Sorrentino, | anandamide, a brain constituent (231) 313 Endogenous nitric oxide modulates morphine-induced changes in Fu, W.-M., see Liu, S.-H. (231) 23 locomotion and food intake in mice (231) 415 Fujisawa, A., see Shimamura, K. (231) 103 Capogna, M., see Zeise, M.L. (231) 47 Fukutake, K., see Mizuguchi, K. (231) 121 Carroll, F.1., see Walker, J.M. (231) 61 Furukawa, Y., see Takayama, S. (231) 315 Chahl, L.A., see Bot, G. (231) 53 Chan, P., Li, Y., Zheng, Z., Hu, P., Sarbach, $S.D. and Guez, D Gaudry-Talarmain, Y.M., see Moulian, N. (231) 407 Neurologic and histologic evaluation of almitrine + raubasine Gessa, G.L., see Rossetti, Z.L. (231) 203 (Duxil”) in middle cerebral artery occlusion in cats (231) 175 Giembycz, M.A., see Rabe, K.F. (231) 305 Chaouloff, F., Layeillon, C. and Baudrie, V Gilmore, J., see Boot, J.R. (231) 83 5-HT,,-/5-HT, receptor blockade prevents 1-(2,5-dimethoxy-4 Glaser, T., see Baudrie, V. (231) 395 iodopheny!)2-aminopropane-, but not stress-induced increases in Godfraind, T., see Dessy, C. (231) 435 brain tryptophan (231) 77 Gruetter, C.A., see Szarek, J.L. (231) 339 490 Guez, D., see Chan, P. (231) 175 Kobayashi, A., see Suzuki, S. (231) 297 Gulati, A., Arora, R.C. and Crayton, J Koga, Y., see Shibata, S. (231) 381 Central serotonergic uptake mechanisms in hypertensive rats Kogo, H., Takasaki, K., Takeo, S., Watanabe, G., Taya, K. and effects of clonidine and centhaquin (231) 151 Sasamoto, S A role of prostaglandin in the secretion of inhibin and oestradiol- Hacksell, U., see Yu, H. (231) 69 17B in equine chorionic gonadotrophin-primed rats (231) 481 Haefely, W.E., see Jenck, F. (231) 223 Krug, M., Matthies, R., Wagner, M. and Brodemann, R Hamada, T., see Shibata, S. (231) 381 Non-opioid antitussives and methadone differentially influence Hammond, D.L. and Bloss, J.1 hippocampal long-term potentiation in freely moving rats (231) Antinociceptive effects of SC-39566, an opioid dipeptide arylal- 355 kylamide, in the Rhesus monkey (231) 281 Kuribara, H Harada, K., see Ohta, H. (231) 323 Ceruletide, a cholecystokinin-like decapeptide, differentially re- Harada, M., see Arimura, A. (231) 13 duces the stimulant effect of MK-801 and ketamine: evaluation Haruno, A., see Matsuzaki, T. (231) 363 by discrete shuttle avoidance in mice (231) 7 Hashimoto, K., see Matsuzaki, T. (231) 363 Kurosawa, A., see Arimura, A. (231) 13 Hashimoto, S., Kigoshi, S. and Muramatsu, | Nitric oxide-dependent and -independent neurogenic relaxation Labie, C., Keane, P.E., Soubrié, P. and Le Fur, G of isolated dog urethra (231) 209 The o receptor ligand SR 31742A increases neurotensin in the Herman, A.G., see Van Diest, M.J. (231) 267 nucleus accumbens but not in the caudate-putamen of the rat Hirata, Y., Takiguchi, Y., Wada, K., Matsuno, H., Umemura, K., (231) 465 Uematsu, T. and Nakashima, M Layeillon, C., see Chaouloff, F. (231) 77 Roles of platelet-activating factor, thromboxane A,, ADP and Lé, A.D., see Wu, P.H. (231) 157 thrombin in thrombogenesis in the guinea pig (231) 421 Le Fur, G., see Labie, C. (231) 465 Hmaidan, Y., see Rossetti, Z.L. (231) 203 Lehmkuhl, A., see Hoey, A. (231) 477 Hoey, A., Lehmkuhl, A., Sadony, V. and Ravens, U Lemaire, S., see Shukla, V.K. (231) 293 Inotropic actions of BDF 9148 and DPI 201-106 and their enan Lewander, T., see Yu, H. (231) 69 tiomers in guinea-pig, rat and human atria (231) 477 Li, Y., see Chan, P. (231) 175 Hong, K.W., Park, M.G., Shin, Y.W., Rhim, B.Y. and Ko, K.H Lindberg, S. and Dolata, J Effect of ouabain on relaxation induced by cromakalim in human NK, receptors mediate the increase in mucociliary activity pro and canine mesenteric arteries (231) 1 duced by tachykinins (231) 375 Hori, M., see Karaki, H. (231) 371 Lin-Shiau, S.-Y., see Liu, $.-H. (231) 23 Hu, P., see Chan, P. (231) 175 Liu, G.J. and Takeuchi, H Huang, K.-X., see Sun, B.-C. (231) 331 AJ-2615, a long-acting Ca** channel antagonist with a novel Hudkins, R.L., Stubbins, J.F. and DeHaven-Hudkins, D.L. structure (231) 91 Caramiphen, iodocaramiphen and nitrocaramiphen are potent, Liu, J.-F., see Wu, P.H. (231) 157 competitive, muscarinic M, receptor-selective agents (231) 485 Liu, S.-H., Fu, W.-M. and Lin-Shiau, S.-Y Hudson, G.M., see Young, G.A. (231) 473 Studies on the inhibition by chlorpromazine of myotonia induced Hyslop, S., see Santana, A.C. (231) 237 by ion channel modulators in mouse skeletal muscle (231) 23 Liu, Y., see Yu, H. (231) 69 Inoue, Y., see Takayama, S. (231) 315 Lockwood, M., see Patrick, $.L. (231) 243 Ishibashi, M., see Mizuguchi, K. (231) 121 Loh, H.H., see Tao, P.-L. (231) 145 Israél, M., see Moulian, N. (231) 407 Léscher, W., see Richter, A. (231) 111 Ivorra, M.D., Chulia, S., Lugnier, C. and D’Ocon, M.P Léscher, W., see Richter, A. (231) 287 Selective action of two aporphines at a,-adrenoceptors and po- Léschmann, P.-A., see Richter, A. (231) 287 tential-operated Ca?* channels (231) 165 Lugnier, C., see Ivorra, M.D. (231) 165 Lundy, P.M. and Frew, R Jenck, F., Moreau, J.-L., Mutel, V., Martin, J.R. and Haefely, W.E Pharmacological characterization of voltage-sensitive Ca~* chan Evidence for a role of 5-HT,. receptors in the antiserotonergic nels in autonomic nerves (231) 197 properties of some antidepressant drugs (231) 223 Jin, G.-Z., see Sun, B.-C. (231) 331 Maggi, C.A., see Santicioli, P. (231) 139 Jinno, Y., see Ohta, H. (231) 323 Mancuso, F., see Calignano, A. (231) 415 Junien, J.-L., see Pascaud, X.B. (231) 389 Marin, C. and Chase, T.N Jun Liu, G. and Takeuchi, H Dopamine D, receptor stimulation but not dopamine D, recep Modulatory effects of achatin-l, an Achatina endogenous neu tor stimulation attenuates haloperidol-induced behavioral super- roactive peptide, on responses to 5-hydroxytryptamine (231) 259 sensitivity and receptor up-regulation (231) 191 Martin, J.R., see Jenck, F. (231) 223 Kalan, H., see Wu, P.H. (231) 157 Masada, A., see Mizuguchi, K. (231) 121 Kameyama, T., see Ukai, M. (231) 143 Mascarella, $.W., see Walker, J.M. (231) 61 Karaki, H., Sudjarwo, S.A., Hori, M., Sakata, K., Urade, Y., Takai, Matsuno, H., see Hirata, Y. (231) 421 M. and Okada, T Matsuno, K., Senda, T. and Mita, S ET, receptor antagonist, IRL 1038, selectively inhibits the en- Correlation between potentiation of neurogenic twitch contrac- dothelin-induced endothelium-dependent vascular relaxation tion and benzomorphan o receptor binding potency in the mouse (231) 371 vas deferens (231) 451 Kasparov, S., see Zeise, M.L. (231) 47 Matsuzaki, T., Haruno, A. and Hashimoto, K. Keane, P.E., see Labie, C. (231) 465 Effects of gallopamil, a Ca?* channel blocker in models of Kigoshi, S., see Hashimoto, S. (231) 209 ventricular arrhythmia in dogs (231) 363 Ko, K.H., see Hong, K.W. (231) 1 Matthies, R., see Krug, M. (231) 355 491 McAllister, K.H In vivo characterization of a phosphoramidon-sensitive endothe- Antagonism of non-NMDA receptors inhibits handling-induced, lin-converting enzyme in the rat (231) 459 strychnine-potentiated convulsions (231) 309 Potier, B. and Dutar, P Mechoulam, R., see Fride, E. (231) 313 Presynaptic inhibitory effect of baclofen on hippocampal in- Meldrum, B.S., see Chapman, A.G. (231) 301 hibitory synaptic transmission involves a pertussis toxin-sensitive Mihic, S.J., see Wu, P.H. (231) 157 G-protein (231) 427 Milicic, 1., see Pollock, D.M. (231) 459 Prinssen, E.P.M., Ellenbroek, B.A., Stamatovic, B. and Cools, A.R Mita, S., see Matsuno, K. (231) 451 The effects of haloperidol and raclopride in the paw test are Miura, M., see Belvisi, M.G. (231) 97 influenced similarly by SCH 39166 (231) 275 Miwa, A., see Ohta, H. (231) 323 Pruneau, D. and Bélichard, P Miyake, H., see Takeuchi, K. (231) 135 Endothelium-dependent control of vascular tone in the rabbit Mizota, M., see Mizuguchi, K. (231) 121 kidney after ischemia and reperfusion (231) 215 Mizuguchi, K., Yano, T., Tanaka, Y., Ishibashi, M., Masada, A Mizota, M., Fukutake, K. and Saito, Y Rabe, K.F., Giembycz, M.A., Dent, G., Perkins, R.S., Evans, P. and Mechanism of the lipid-lowering effect of ethyl all-cis Barnes, PJ 5,8,11,14,17-icosapentaenoate (231) 121 Salmeterol is a competitive antagonist at B-adrenoceptors medi Moreau, J.-L., see Jenck, F. (231) 223 ating inhibition of respiratory burst in guinea-pig eosinophils Morel, N., see Dessy, C. (231) 435 (231) 305 Mori, E., see Ukai, M. (231) 143 Rahman, S. and Neuman, R.S Moulian, N., Gaudry-Talarmain, Y.M. and Israél, M Activation of 5-HT, receptors facilitates depolarization of neo- The effect of MR16728, a cetiedil analogue, on acetylcholine cortical neurons by N-methyl-D-aspartate (231) 347 release in Torpedo synaptosomes (231) 407 Raiteri, M., see Pittaluga, A. (231) 129 Muramatsu, I., see Hashimoto, S. (231) 209 Ravens, U., see Hoey, A. (231) 477 Mutel, V., see Jenck, F. (231) 223 Remacle-Volon, G., see Damas, J. (231) 231 Ren, L.-M., see Takayama, S. (231) 315 Nakashima, M., see Hirata, Y. (231) 421 Rhim, B.Y., see Hong, K.W. (231) 1 Nakazawa, H., see Ohta, H. (231) 323 Richter, A. and Léscher, W Nakazawa, K., see Suzuki, S. (231) 297 Alterations in pharmacological sensitivity of GABAergic but not Neuman, R.S., see Rahman, S. (231) 347 dopaminergic and glutamatergic systems during ontogenesis in Niki, S., see Takeuchi, K. (231) 135 dystonic mutant hamsters (231) 111 Nishikori, K., see Ohta, H. (231) 323 Richter, A., Léscher, W. and Léschmann, P.-A Novosad, E.1., see Pollock, D.M. (231) 459 The AMPA receptor antagonist NBOX exerts antidystonic ef- fects in an animal model of idiopathic dystonia (231) 287 O’Brien, A., see Boot, J.R. (231) 83 O'Connor, S.E., see Choppin, A. (231) 469 Risiglione, C., see Pittaluga, A. (231) 129 Ogawa, N., see Ohta, H. (231) 323 Rossetti, Z.L., Hmaidan, Y., Diana, M. and Gessa, G.I Ohta, H., Nakazawa, H., Jinno, Y., Harada, K., Ogawa, N., Miwa, A Lack of tolerance to ethanol-induced dopamine release in the rat and Nishikori, K ventral striatum (231) 203 Effects of K* channel openers on ischemic dysfunction and Roze, C., see Pascaud, X.B. (231) 389 metabolic disturbance in isolated perfused rat heart (231) 323 Sabater, R., see Ferrer, J.M.R. (231) 39 Ohuchi, T., see Takeuchi, K. (231) 135 Okabe, S., see Takeuchi, K. (231) 135 Sadony, V., see Hoey, A. (231) 477 Okada, T., see Karaki, H. (231) 371 Saez, J.A., see Ferrer, J.M.R. (231) 39 Opgenorth, T.J., see Pollock, D.M. (231) 459 Saito, Y., see Mizuguchi, K. (231) 121 Orito, K., Satoh, K. and Taira, N Sakamoto, T., Barnes, PJ. and Chung, K.F Involvement of ATP-sensitive K* channels in the sustained coro Effect of CP-96,345, a non-peptide NK, receptor antagonist, nary vasodilator response to adenosine in dogs (231) 183 against substance P-, bradykinin- and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig Park, M.G., see Hong, K.W. (231) 1 (231) 31 Pascaud, X.B., Chovet, M., Roze, C. and Junien, J.-1 Sakata, K., see Karaki, H. (231) 371 Neuropeptide Y and o receptor agonists act through a common Salomone, S., see Dessy, C. (231) 435 pathway to stimulate duodenal alkaline secretion in rats (231) 389 Santana, A.C., Hyslop, S., Antunes, E., De Nucci, G. and Bakhle, Patrick, R.L., see Patrick, $.L. (231) 243 YS Patrick, S.L., Walker, J.M., Perkel, J.M., Lockwood, M. and Patrick Anti-inflammatory activities of Ph CL28A in rats in vivo (231) 237 R.1 Santicioli, P., Del Bianco, E. and Maggi, C.A Increases in rat striatal extracellular dopamine and vacuous Adenosine A, receptors mediate the presynaptic inhibition of chewing produced by two o receptor ligands (231) 243 calcitonin gene-related peptide release by adenosine in the rat Patrick, S.L., see Walker, J.M. (231) 61 spinal cord (231) 139 Perkel, J.M., see Patrick, S.L. (231) 243 Sarbach, S.D., see Chan, P. (231) 175 Perkins, R.S., see Rabe, K.F. (231) 305 Sasamoto, S., see Kogo, H. (231) 481 Persico, P., see Calignano, A. (231) 415 Satoh, H. and Sperelakis, N Pittaluga, A., Fedele, E., Risiglione, C. and Raiteri, M Effects of taurine on Ca** currents in young embryonic chick Age-related decrease of the NMDA receptor-mediated nor cardiomyocytes (231) 443 adrenaline release in rat hippocampus and partial restoration by Satoh, K., see Orito, K. (231) 183 D-cycloserine (231) 129 Sawaki, S., see Takayama, S. (231) 315 Polgar, W.E., see Webster, J.L. (231) 251 Schmidt, B., see Baudrie, V. (231) 395 Pollock, D.M., Divish, B.J., Milicic, 1., Novosad, E.1., Burres, N.S Senda, T., see Matsuno, K. (231) 451 and Opgenorth, T.J Seybold, V.S., see Tao, P.-L. (231) 145 492 Shibata, S., Koga, Y., Hamada, T. and Watanabe, S$ Taya, K., see Kogo, H. (231) 481 Facilitation of 2-deoxyglucose uptake in rat cortex and hippocam Thomas, K.H., see Boot, J.R. (231) 83 pus slices by somatostatin is independent of cholinergic activity Toda, N., see Shimamura, K. (231) 103 (231) 381 Todd, A., see Boot, J.R. (231) 83 Shimamura, K., Fujisawa, A., Toda, N. and Sunano, S Toll, L., see Webster, J.L. (231) 251 Effects of N“-nitro-L-arginine on electrical and mechanical re sponses to stimulation of non-adrenergic, non-cholinergic in Uematsu, T., see Hirata, Y. (231) 421 hibitory nerves in circular muscle of the rat gastric fundus (231) Ukai, M., Mori, E. and Kameyama, T 103 Cocaine-like discriminative stimulus properties of the 6-selective Shin, Y.W., see Hong, K.W. (231) 1 opioid receptor agonist, [D-Pen*,L-Pen* Jenkephalin, in the rat Shukla, V.K. and Lemaire, S (231) 143 Norbinaltorphimine protection against N-methyl-D-aspartic Umemura, K., see Hirata, Y. (231) 421 acid-induced convulsions and mortality (231) 293 Urade, Y., see Karaki, H. (231) 371 Sorrentino, L., see Calignano, A. (231) 415 Soubrié, P., see Labie, C. (231) 465 Van Diest, M.J., Verbeuren, T.J. and Herman, A.G Sperelakis, N., see Satoh, H. (231) 443 Vascular interaction between 5-hydroxytryptamine and Stamatovic, B., see Prinssen, E.P.M. (231) 275 oxygenase metabolites of arachidonic acid (231) 267 Stamidis, H., see Young, G.A. (231) 473 Verbeuren, T.J., see Van Diest, M.J. (231) 267 Steinfels, G.F., see Young, G.A. (231) 473 Stretton, D., see Belvisi, M.G. (231) 97 Wada, K., see Hirata, Y. (231) 421 Stubbins, J.F., see Hudkins, R.L. (231) 485 Wagner, M., see Krug, M. (231) 355 Sudjarwo, S.A., see Karaki, H. (231) 371 Walker, J.M., Bowen, W.D., Patrick, S.I Williams, W.E., Mas Sugita, S., see Suzuki, S. (231) 297 carella, $.W., Bai, X. and Carroll, F.1 Sun, B.-C., Huang, K.-X. and Jin, G.-Z A comparison of (— )-deoxybenzomorphans devoid of opiate ac Repeated reserpine treatment alters firing pattern and responses tivity with their dextrorotatory phenolic counterparts suggests of substantia nigral dopamine neurons (231) 331 role of a) receptors in motor function (231) 61 Sunano, S., see Shimamura, K. (231) 103 Walker, J.M., see Patrick, S.L. (231) 243 Suzuki, S., Yoshida, T., Sugita, $., Kobayashi, A. and Nakazawa, K Watanabe, G., see Kogo, H. (231) 481 Triiodothyronine increases desipramine with changing the con Watanabe, S., see Shibata, S. (231) 381 centrations of monoamines, in the brain of rat given imipramine Webster, J.L., Polgar, W.E., Brandt, S$.R., Berzetei-Gurske, 1.P. and (231) 297 Toll, I Szarek, J.L., Zhang, J.Z. and Gruetter, C.A Comparison of «,-opioid receptors in guinea pig brain and guinea 5-HT, receptors augment cholinergic nerve-mediated contraction pig ileum membranes (231) 251 of rat bronchi (231) 339 Williams, W.E., see Walker, J.M. (231) 61 Wu, P.H., Mihic, S.J., Liu, J.-F., Lé, A.D. and Kalan, H Taira, N., see Orito, K. (231) 183 Blockade of chronic tolerance to ethanol by the NMDA antago Takai, M., see Karaki, H. (231) 371 nist, (+ )}-MK-801 (231) 157 Takasaki, K., see Kogo, H. (231) 481 Takayama, S., Furukawa, Y., Ren, L.-M., Inoue, Y., Sawaki, S. and Yagi, H., see Arimura, A. (231) 13 Chiba, S$ Yano, T., see Mizuguchi, K. (231) 121 Positive chronotropic and inotropic responses to BRL 37344, a Yoshida, T., see Suzuki, S. (231) 297 B,-adrenoceptor agonist in isolated, blood-perfused dog atria Young, G.A., Hudson, G.M., Stamidis, H. and Steinfels, G.I (231) 315 Interactions between U-50,488H and o receptor antagonists Takeo, S., see Kogo, H. (231) 481 EEG, EEG power spectral and behavioral correlates (231) 473 Takeuchi, H., see Jun Liu, G. (231) 259 Yu, H., Liu, Y., Hacksell, U. and Lewander, T Takeuchi, H., see Liu, G.J. (231) 91 (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel Takeuchi, K., Ohuchi, T., Miyake, H., Niki, S. and Okabe, S 5-HT,, receptor agonists (231) 69 Effects of nitric oxide synthase inhibitors on duodenal alkaline secretion in anesthetized rats (231) 135 Zeise, M.L., Kasparov, S., Capogna, M. and Zieglgansberger, W Takiguchi, Y., see Hirata, Y. (231) 421 Acamprosate (calciumacetylhomotaurinate) decreases postsynap Tanaka, Y., see Mizuguchi, K. (231) 121 tic potentials in the rat neocortex: possible involvement of excita Tao, P.-L., Seybold, V.S. and Loh, H.H tory amino acid receptors (231) 47 Autoradiographic evidence for decrease in binding of u- and Zhang, J.Z., see Szarek, J.L. (231) 339 5-opioid receptors after subchronic [D-Ala*,D-Leu* Jenkephalin Zheng, Z., see Chan, P. (231) 175 treatment in rats (231) 145 Zieglgansberger, W., see Zeise, M.L. (231) 47 European Journal of Pharmacology, 231 (1993) 493-504 © 1993 Elsevier Science Publishers B.V. All rights reserved 0014-2999 /93 /$06.00 Key word index Acamprosate (calciumacetylhomotaurinate ) Airway microvascular leakage Excitatory amino acids; GABA (y-aminobutyric acid); Neocortex Allergen; Bradykinin; CP-96,345; NK receptors; Substance P Postsynaptic potentials; Neurotransmission (Zeise, M.L. (231) 47) (Sakamoto, T. (231) 31) Acetylcholine AJ-2615 Somatostatin; 2-Deoxyglucose; Cerebral cortex; Hippocampus Ca channel antagonists; lon channels; (Neurons), (Snail) (Liu, Acetylcholine receptors (Shibata, S$. (231) 381) G.J. (231) 91) Acetylcholine receptors Allergen Somatostatin; 2-Deoxyglucose; Cerebral cortex; Hippocampus Bradykinin; CP-96,345; Airway microvascular leakage; NK, recep Acetylcholine (Shibata, S. (231) 381) tors; Substance P (Sakamoto, T. (231) 31) Acetylcholine release Almitrine Ca**; Cetiedil; Cholinergic synapses; Mediatophore; (Torpedo mar Raubasine; Middle cerebral artery; Ischemia; Penumbra; (Cat) (Chan morata synaptosomes) (Moulian, N. (231) 407) P. (231) 175) Achatin-1 D-Amino acid residue D-Amino acid residue; Molluscan peptide; 5-HT (5-hydroxytrypta Achatin-Il; Molluscan peptide; 5-HT (5-hydroxytryptamine, sero mine, serotonin); Modulatory effects; Voltage clamp; Neurons; (Snail) tonin); Modulatory effects; Voltage clamp; Neurons; (Snail) Jun Liu, (Jun Liu, G. (231) 259) G. (231) 259) Adenosine AMPA (a@-amino-3-hydroxy-5-methyl-4-isoxazole propionate) Norbinaltorphimine; NMDA (N-methyl-D-aspartate),; Convulsion; Antinociception; Adenosine receptors; Sensory neuropeptides; Cap Mortality (Shukla, V.K. (231) 293) saicin (Santicioli, P. (231) 139) AMPA receptor antagonists Adenosine A receptor-mediated vasodilatation; K channels DBA/2 mice Aniracetam; NBOX (2,3-dihydroxy-6-nitro-7 (ATP-sensitive); 8-Phenyltheophylline; Glibenclamide (Orito, K sulfamoylbenzo(F )quinoxaline); GYKI 52466 (144-aminophenyl)-4 (231) 183) methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine -H Cl); CPPene (D( — )}( E)-4-3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid) Adenosine A, receptor-mediated vasodilatation (Chapman, A.G. (231) 301) Adenosine; K channels (ATP-sensitive), 8-Phenyltheophylline Glibenclamide (Orito, K. (231) 183) Aniracetam DBA/2 mice; AMPA receptor antagonists; NBOX (2,3-dihydroxy Adenosine receptors 6-nitro-7-sulfamoylbenzo(F )quinoxaline); GYKI 52466 (1-44 Adenosine; Antinociception; Sensory neuropeptides; Capsaicin aminopheny|)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine (Santicioli, P. (231) 139) HCl); CPPene (D(— )4E)-4-43-phosphonoprop-2-enyl) piperazine-2 carboxylic acid) (Chapman, A.G. (231) 301) ADP Thrombosis; Thromboxane A PAF (platelet-activating factor Antidepressants PAF-acether), Thrombin; (Guinea-pig) (Hirata, Y. (231) 421) 5-HT (S-hydroxytryptamine, serotonin); 5-HT,,. receptors; 5-HT A receptors; (Rat) (Jenck, F. (231) 223) a ,-Adrenoceptor antagonists Ca channel antagonists; Aorta (rat); Aporphines; Phosphodi Antinociception esterase inhibitors (Ivorra, M.D. (231) 165) Adenosine; Adenosine receptors; Sensory neuropeptides; Capsaicin (Santicioli, P. (231) 139) 8 -Adrenoceptors Eosinophils; Respiratory burst; Salmeterol; Eformoterol; Salbutamol Shock titration; Opioid peptides; Rhesus monkey; SC-39566 (Ham (Rabe, K.F. (231) 305) mond, D.L. (231) 281) B ,-Adrenoceptors Antipsychotics BRL 37344; Chronotropism; Inotropism; Heart (dog) (Takayama, S SR 31742A; Neurotensin; o Receptor ligands (Labie, C. (231) 465) (231) 315) Anxiolysis Aging Ipsapirone; DOI (1-2,5-dimethoxy-4-iodophenyl )-2-aminopropane) NMDA receptors; Glycine; D-Cycloserine; Noradrenaline release 5-HT,, receptors; 5-HT, receptors; Glucose; Corticosterone; Pro Glycine uptake (Pittaluga, A. (231) 129) lactin; Behaviour (Baudrie, V. (231) 395) 494 Aorta (rat) Big endothelin-3 Ca?* channel antagonists; a,-Adrenoceptor antagonists; Apor- Endothelin-converting enzyme; Big endothelin-1; Phosphoramidon; phines; Phosphodiesterase inhibitors (Ivorra, M.D. (231) 165) Endothelin; Hemodynamics; (Rat) (Pollock, D.M. (231) 459) Smooth muscle (vascular); Endothelium (vascular); EDRF (endo- Blood-brain barrier thelium-derived relaxing factor); Endothelins; ET, receptors; ET, Tryptophan; 5-HT,,.. /5-HT, receptors; Sympathetic nervous system; receptor antagonists; IRL 1038 (Karaki, H. (231) 371) Immobilization stress (Chaouloff, F. (231) 77) $312; Dihydrothienopyridine; Cerebral microvessels (rat); Dihy- Blood pressure dropyridine binding site; Phenylalkylamine binding site (Dessy, C Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Cen- (231) 435) thaquin; Central nervous system (CNS); 5-HT uptake sites (Gulati, A. (231) 151) Aporphines Ca** channel antagonists; a,-Adrenoceptor antagonists; Aorta (rat); Blood vessels Phosphodiesterase inhibitors (Ivorra, M.D. (231) 165) Contractions; 5-HT (5-hydroxytryptamine, serotonin); Lipoxygenase products; Atherosclerosis; (Interaction) (Van Diest, M.J. (231) 267) Atherosclerosis Contractions; 5-HT (S-hydroxytryptamine, serotonin); Lipoxygenase Bradykinin products; Blood vessels; (Interaction) (Van Diest, M.J. (231) 267) Allergen; CP-96,345; Airway microvascular leakage; NK, receptors; Substance P (Sakamoto, T. (231) 31) ATP transmission o Receptor ligands; Neurogenic twitch contraction; Benzomorphan- Brain (guinea-pig) type o receptor; Vas deferens (mouse); Brain (guinea-pig); SK&F oa Receptor ligands; Neurogenic twitch contraction; Benzomorphan- 10,047 (N-allylnormetazocine); Rimcazole; Haloperidol (Matsuno, K type o receptor; ATP transmission; Vas deferens (mouse); SK&F (231) 451) 10,047 (N-allylnormetazocine); Rimcazole; Haloperidol (Matsuno, K (231) 451) Autonomic nerves w-Conotoxin GVIA; Ca’* channels (voltage-sensitive); Hololena Bremazocine curta venom; Funnel web spider toxin; Neurotransmitter release «-Opioid receptors; Dynorphin; Ileum (guinea-pig) (Webster, J.1 (Lundy, P.M. (231) 197) (231) 251) Autoradiography BRL 37344 Tolerance; DADLE ({D-Ala?,D-Leu* Jenkephalin); Opioid receptors; B,-Adrenoceptors; Chronotropism; Inotropism; Heart (dog) (Rat) (Tao, P.-L. (231) 145) (Takayama, S. (231) 315) Dopamine receptors; Stereotypies; Behavioral supersensitivity (Marin, C. (231) 191) Bronchial hyperresponsiveness $-1452 (calcium (1R,2S,3S,4S)-(5Z)-7-(((phenylsulfonyl)amino)bi cyclo[2.2.1}hept-2-yDhept-5-enoate dihydrate); Thromboxane A,; Avoidance behaviour Lipopolysaccharide; TNF (tumor necrosis factor) (Arimura, A. (231) MK-801; Ketamine; Methamphetamine; Ceruletide; Cholecys- tokinin-like decapeptide; Dopamine release (Kuribara, H. (231) 7) 13) Bronchi (rat) BDF 9148 DPI 201-106; Positive inotropy; (Enantiomers) (Hoey, A. (231) 477) 5-HT (S-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta mine; 5-HT, receptors; Ketanserin; Mianserin; Spiperone; Electrical field stimulation; Cholinergic nerves (Szarek, J.L. (231) 339) Behavioral supersensitivity Dopamine receptors; Stereotypies; Autoradiography (Marin, C. (231) Ca** 191) Acetylcholine release; Cetiedil; Cholinergic synapses; Mediatophore; Behaviour (Torpedo marmorata synaptosomes) (Moulian, N. (231) 407) Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Glucose; Corticos- Ca** channel antagonists terone; Prolactin (Baudrie, V. (231) 395) AJ-2615; lon channels; (Neurons); (Snail) (Liu, G.J. (231) 91) Benzomorphan-type o receptor a,-Adrenoceptor antagonists; Aorta (rat); Aporphines; Phosphodi- oa Receptor ligands; Neurogenic twitch contraction; ATP transmis esterase inhibitors (Ivorra, M.D. (231) 165) sion; Vas deferens (mouse); Brain (guinea-pig); SK&F 10,047 (N-al- lylinormetazocine); Rimcazole; Haloperidol (Matsuno, K. (231) 451) Ca** channels (L-type) Taurine; Ca** channels (T-type); Cardiac myocytes; Heart cells Bicarbonate secretion (embryonic chick); Voltage clamp (whole cell); Electrophysiology Neuropeptide Y (NPY); a Receptors; CCK (cholecystokinin); Duo- (Satoh, H. (231) 443) denum; (Rat) (Pascaud, X.B. (231) 389) Ca** channels (T-type) Big endothelin-1 Taurine; Ca** channels (L-type); Cardiac myocytes; Heart cells Endothelin-converting enzyme; Big endothelin-3; Phosphoramidon; (embryonic chick); Voltage clamp (whole cell); Electrophysiology Endothelin; Hemodynamics; (Rat) (Pollock, D.M. (231) 459) (Satoh, H. (231) 443) Ca** channels (voltage-sensitive) Cholecystokinin-like decapeptide w-Conotoxin GVIA; Hololena curta venom; Funnel web spider toxin; MK-801; Ketamine; Methamphetamine; Ceruletide; Dopamine re- Neurotransmitter release; Autonomic nerves (Lundy, P.M. (231) 197) lease; Avoidance behaviour (Kuribara, H. (231) 7) Cannabinoids Cholesterol metabolism Tetrahydrocannabinol; Marihuana (Fride, E. (231) 313) EPA-E (ethyl all-cis-5,8,11,14,17-icosapentaenoate); (Rat) (Mizu- guchi, K. (231) 121) Capsaicin Adenosine; Antinociception; Adenosine receptors; Sensory neu- Cholinergic nerves ropeptides (Santicioli, P. (231) 139) 5-HT (5-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta mine; Bronchi (rat); 5-HT, receptors; Ketanserin; Mianserin; Spiper- Caramiphen one; Electrical field stimulation (Szarek, J.L. (231) 339) lodocaramiphen; Nitrocaramiphen: Muscarinic receptor antagonists; Muscarinic M, receptors; (Rat) (Hudkins, R.L. (231) 485) Cholinergic neurotransmission VIP (vasoactive intestinal polypeptide); Nitric oxide (NO); Inhibitory Carbachol non-adrenergic non-cholinergic (i-NANC); Electrical field stimula- Pertussis toxin; Morphine; Substance P; Quinpirole; U-50,488H (Bot, tion (Belvisi, M.G. (231) 97) G. (231) 53) Cholinergic synapses 5-Carboxamidotryptamine Acetylcholine release; Ca? *; Cetiedil; Mediatophore; (Torpedo mar- Vascular 5-HT,-like receptors; 5-HT (S-hydroxytryptamine, sero morata synaptosomes) (Moulian, N. (231) 407) tonin); (Effect of pre-contraction) (Choppin, A. (231) 469) Chronotropism Cardiac myocytes BRL 37344; 8,-Adrenoceptors; Inotropism; Heart (dog) (Takayama, Taurine; Ca** channels (L-type); Ca** channels (T-type); Heart S. (231) 315) cells (embryonic chick); Voltage clamp (whole cell); Electrophysiol ogy (Satoh, H. (231) 443) Cilia Maxillary sinus; Mucociliary activity; Phosphoramidon; Tachykinins; Carrageenan Tachykinin receptors; (Rabbit) (Lindberg, S. (231) 375) Oedema; Ph CL28A; Pleurisy; Prostacyclin; Thromboxane (Santana, A.C, (231) 237) Clonidine Spontaneously hypertensive rat (SHR); Imipramine; Centhaquin; CCK (cholecystokinin) Blood pressure; Central nervous system (CNS); 5-HT uptake sites Neuropeptide Y (NPY); o Receptors; Bicarbonate secretion; Duo (Gulati, A. (231) 151) denum; (Rat) (Pascaud, X.B. (231) 389) Cocaine Centhaquin [D-Pen?,I -Pen” Jenkephalin; Naltrindole (Ukai, M. (231) 143) Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Blood pressure; Central nervous system (CNS); 5-HT uptake sites (Gulati, Codeine A. (231) 151) Dentate gyrus; Field potentials; Long-term potentiation; NMDA receptors; Dextromethorphan; Methadone; Normethadone; MK 801 Central nervous system (CNS) (Krug, M. (231) 355) Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Cen thaquin; Blood pressure; 5-HT uptake sites (Gulati, A. (231) 151) Complement Zymosan; PAF (platelet-activating factor, PAF-acether); WEB 2086 Cerebral cortex SM-12502; Plasma leakage (Damas, J. (231) 231) Somatostatin; 2-Deoxyglucose; Hippocampus; Acetylcholine; Acetyl- choline receptors (Shibata, S. (231) 381) w-Conotoxin GVIA Ca** channels (voltage-sensitive); Hololena curta venom; Funnel Cerebral microvessels (rat) web spider toxin; Neurotransmitter release; Autonomic nerves $312; Dihydrothienopyridine; Aorta (rat); Dihydropyridine binding (Lundy, P.M. (231) 197) site; Phenylalkylamine binding site (Dessy, C. (231) 435) Contractions Ceruletide 5-HT (5-hydroxytryptamine, serotonin); Lipoxygenase products; MK-801; Ketamine; Methamphetamine; Cholecystokinin-like de- Atherosclerosis; Blood vessels; (Interaction) (Van Diest, M.J. (231) capeptide; Dopamine release; Avoidance behaviour (Kuribara, H 267) (231) 7) Convulsion Cetiedil Norbinaltorphimine; NMDA _ (N-methyl-D-aspartate); AMPA Acetylcholine release; Ca**; Cholinergic synapses; Mediatophore; (a-amino-3-hydroxy-5-methyl-4-isoxazole propionate); Mortality (Torpedo marmorata synaptosomes) (Moulian, N. (231) 407) (Shukla, V.K. (231) 293) Chlorpromazine Cortex Soleus muscle; Extensor digitorum longus muscle; Myotonic depres 5-HT (5-hydroxytryptamine, serotonin); NMDA (N-methyl-D-aspar- sion (Liu, S.-H. (231) 23) tate); Transmitter interaction (Rahman, S. (231) 347) 496 Corticosterone DOI (1-(2,5-dimethoxy-4-iodopheny!)-2-aminopropane) Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodopheny! )-2-aminopropane ) Ipsapirone; 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Glucose 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Glucose; Prolactin; Corticosterone; Prolactin; Behaviour (Baudrie, V. (231) 395) Behaviour (Baudrie, V. (231) 395) Dopamine Coupling mechanism Dystonia; Phenobarbital; GABA (y-aminobutyric acid); Glutamate GABA, receptors; Hippocampus (Potier, B. (231) 427) Haloperidol (Richter, A. (231) 111) CP-96,345 Microdialysis; Ethanol reinforcement; Tolerance (Rossetti, Z.L. (231) on Allergen; Bradykinin; Airway microvascular leakage; NK, receptors; 203) Substance P (Sakamoto, T. (231) 31) oa Receptor ligands; Microdialysis; Vacuous chewing; DTG (1,3-di CPPene (D(—)-(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-car o-tolylguanidine); (+ )-Pentazocine (Patrick, $.L. (231) 243) boxylic acid) DBA/2 mice; Aniracetam; AMPA receptor antagonists; NBOX Dopamine neurons (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo( F )quinoxaline); GYKI 52466 Reserpine; Substantia nigra pars compacta; Dopamine receptor ago (1-44-aminopheny])-4-methyl-7,8-methylenedioxy-5H-2,3-benzodi- nists; Firing pattern; Single-unit recording; Supersensitivity (Sun, azepine -H Cl) (Chapman, A.G. (231) 301) B.-C. (231) 331) Cromakalim Dopamine receptor agonists Na*.K* ATPase pump; K* channels; Smooth muscle (vascular) Reserpine; Substantia nigra pars compacta; Dopamine neurons; Fir (Hong, K.W. (231) 1) ing pattern; Single-unit recording; Supersensitivity (Sun, B.-C. (231) 331) KRN2391; Heart (isolated, rat); Myocardial ischemia; Energy metabolism (Ohta, H. (231) 323) Dopamine receptors Stereotypies; Behavioral supersensitivity; Autoradiography (Marin, D-Cycloserine C. (231) 191) Aging; NMDA receptors; Glycine; Noradrenaline release; Glycine uptake (Pittaluga, A. (231) 129) Dopamine D, receptors Paw test; SCH 39166; Raclopride; Haloperidol; Dopamine D, recep DADLE (({D-Ala*,D-Leu*]enkephalin) tors (Prinssen, E.P.M. (231) 275) Tolerance; Opioid receptors; Autoradiography; (Rat) (Tao, P.-l (231) 145) Dopamine D, receptors Paw test; SCH 39166; Raclopride; Haloperidol; Dopamine D, recep DBA/2 mice tors (Prinssen, E.P.M. (231) 275) Aniracetam; AMPA receptor antagonists; NBOX (2,3-dihydroxy-6 nitro-7-sulfamoylbenzo(F )quinoxaline); GYKI 52466 (1-(4 Dopamine release aminopheny])-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine MK-801; Ketamine; Methamphetamine; Ceruletide; Cholecys HCl); CPPene (D(— )-(E)-4-(3-phosphonoprop-2-enyl) piperazine-2 tokinin-like decapeptide; Avoidance behaviour (Kuribara, H. (231) 7) carboxylic acid) (Chapman, A.G. (231) 301) DPI 201-106 Dentate gyrus BDF 9148; Positive inotropy; (Enantiomers) (Hoey, A. (231) 477) Field potentials; Long-term potentiation; NMDA receptors; Dex tromethorphan; Methadone; Codeine; Normethadone; MK 801 DTG (1,3-di-o-tolylguanidine) (Krug, M. (231) 355) o Receptor ligands; Dopamine; Microdialysis; Vacuous chewing; (+ )-Pentazocine (Patrick, $.L. (231) 243) 2-Deoxyglucose Somatostatin; Cerebral cortex; Hippocampus; Acetylcholine; Acetyl Duodenum choline receptors (Shibata, S. (231) 381) Neuropeptide Y (NPY); 2 Receptors; CCK (cholecystokinin); Bicar- bonate secretion; (Rat) (Pascaud, X.B. (231) 389) Desipramine Imipramine; Norepinephrine; 5-HT (5-hydroxytryptamine, serotonin); Duodenum (rat) Triiodothyronine (Suzuki, S. (231) 297) Nitric oxide (NO); NO synthase inhibitors; L-NAME (N°-nitro-l arginine methyl ester); HCO, secretion (Takeuchi, K. (231) 135) Dextromethorphan Dentate gyrus; Field potentials; Long-term potentiation; NMDA DuPont Merck S-7389-4 receptors; Methadone; Codeine; Normethadone; MK 801 (Krug, M U-50,488H; Rimcazole; x-Opioid agonists; a Receptor antagonists; (231) 355) EEG power spectra (Young, G.A. (231) 473) Dihydropyridine binding site Dynorphin $312; Dihydrothienopyridine; Aorta (rat); Cerebral microvessels (rat); «-Opioid receptors; Bremazocine; Ileum (guinea-pig) (Webster, J.1 Phenylalkylamine binding site (Dessy, C. (231) 435) (231) 251) Dihydrothienopyridine Dystonia $312; Aorta (rat); Cerebral microvessels (rat); Dihydropyridine bind- Phenobarbital; Dopamine; GABA (y-aminobutyric acid); Glutamate; ing site; Phenylalkylamine binding site (Dessy, C. (231) 435) Haloperidol (Richter, A. (231) 111) Glutamate; Probenecid (Richter, A. (231) 287) Ethanol reinforcement Dopamine; Microdialysis; Tolerance (Rossetti, Z.L. (231) 203) EDRF (endothelium-derived relaxing factor) Renal arteries; Ischemia; Renal hemodynamics; (Rabbit) (Pruneau, ET, receptor antagonists D. (231) 215) Smooth muscle (vascular); Endothelium (vascular); EDRF (endo thelium-derived relaxing factor), Endothelins; ET, receptors; IRI Smooth muscle (vascular); Endothelium (vascular); Endothelins; ET, 1038; Aorta (rat) (Karaki, H. (231) 371) receptors; ET, receptor antagonists; IRL 1038; Aorta (rat) (Karaki H. (231) 371) ET, receptors Smooth muscle (vascular); Endothelium (vascular); EDRF (endo EEG power spectra thelium-derived relaxing factor), Endothelins; ET, receptor antago U-50,488H; Rimcazole; DuPont Merck S-7389-4; «-Opioid agonists nists; IRL 1038; Aorta (rat) (Karaki, H. (231) 371) o Receptor antagonists (Young, G.A. (231) 473) Excitatory amino acids Eformoterol Acamprosate (calciumacetylhomotaurinate); GABA (y-aminobutyric Eosinophils; Respiratory burst; Salmeterol; Salbutamol; B-Adreno acid), Neocortex; Postsynaptic potentials; Neurotransmission (Zeise, M.L. (231) 47) ceptors (Rabe, K.F. (231) 305) Extensor digitorum longus muscle Electrical field stimulation Chlorpromazine; Soleus muscle; Myotonic depression (Liu, S.-H VIP (vasoactive intestinal polypeptide); Nitric oxide (NO); Choliner (231) 23) gic neurotransmission; Inhibitory non-adrenergic non-cholinergic (i NANC) (Belvisi, M.G. (231) 97) Field potentials Dentate gyrus; Long-term potentiation; NMDA receptors; Dex 5-HT (5-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta tromethorphan; Methadone; Codeine; Normethadone; MK 801 mine; Bronchi (rat); 5-HT, receptors; Ketanserin; Mianserin; Spiper (Krug, M. (231) 355) one; Cholinergic nerves (Szarek, J.L. (231) 339) Firing pattern Electrophysiology Reserpine; Substantia nigra pars compacta; Dopamine neurons; Taurine; Ca** channels (L-type); Ca channels (T-type); Cardiac Dopamine receptor agonists; Single-unit recording; Supersensitivity myocytes; Heart cells (embryonic chick); Voltage clamp (whole cell) (Sun, B.-C. (231) 331) (Satoh, H. (231) 443) Food intake Endothelin Nitric oxide (NO); Morphine-induced locomotion; Morphine Endothelin-converting enzyme; Big endothelin-1; Big endothelin-3 (Calignano, A. (231) 415) Phosphoramidon; Hemodynamics; (Rat) (Pollock, D.M. (231) 459) Funnel web spider toxin Endothelin-converting enzyme w-Conotoxin GVIA; Ca channels (voltage-sensitive); Hololena Big endothelin-1; Big endothelin-3; Phosphoramidon; Endothelin curta venom; Neurotransmitter release; Autonomic nerves (Lundy Hemodynamics; (Rat) (Pollock, D.M. (231) 459) P.M. (231) 197) Endothelins GABA (y-aminobutyric acid) Smooth muscle (vascular); Endothelium (vascular); EDRF (endo Acamprosate (calciumacetylhomotaurinate), Excitatory amino acids thelium-derived relaxing factor); ET, receptors; ET, receptor an Neocortex; Postsynaptic potentials; Neurotransmission (Zeise, M.I tagonists; IRL 1038; Aorta (rat) (Karaki, H. (231) 371) (231) 47) Endothelium (vascular) Dystonia; Phenobarbital; Dopamine; Glutamate; Haloperidol (Rich- ter, A. (231) 111) Smooth muscle (vascular); EDRF (endothelium-derived relaxing fac tor); Endothelins; ET, receptors; ET, receptor antagonists; IRI GABA , receptors 1038; Aorta (rat) (Karaki, H. (231) 371) Hippocampus; Coupling mechanism (Potier, B. (231) 427) Energy metabolism Gallopamil KRN2391; Cromakalim; Heart (isolated, rat); Myocardial ischemia Ventricular arrhythmia; (Triggered activity); (Plasma concentration) (Ohta, H. (231) 323) (Matsuzaki, T. (231) 363) (D-Pen?,L-Pen* Jenkephalin Glibenclamide Cocaine; Naltrindole (Ukai, M. (231) 143) Adenosine; Adenosine A, receptor-mediated vasodilatation; K” channels (ATP-sensitive), 8-Phenyltheophylline (Orito, K. (231) 183) Eosinophils Respiratory burst; Salmeterol; Eformoterol; Salbutamol; B-Adreno Glucose ceptors (Rabe, K.F. (231) 305) Ipsapirone; DOI (1-2,5-dimethoxy-4-iodophenyl)-2-aminopropane), 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Corticosterone; Pro- EPA-E (ethyl all-cis-5,8,11,14,17-icosapentaenoate ) lactin; Behaviour (Baudrie, V. (231) 395) Cholesterol metabolism; (Rat) (Mizuguchi, K. (231) 121) Glutamate Ethanol Dystonia; Phenobarbital; Dopamine; GABA (y-aminobutyric acid), (+ )-MK-801; Tolerance; (Rat) (Wu, P.H. (231) 157) Haloperidol (Richter, A. (231) 111) 498 Dystonia; Probenecid (Richter, A. (231) 287) Achatin-l; D-Amino acid residue; Molluscan peptide; Modulatory effects; Voltage clamp; Neurons; (Snail) (Jun Liu, G. (231) 259) Glycine Aging; NMDA receptors; D-Cycloserine; Noradrenaline release; Contractions; Lipoxygenase products; Atherosclerosis; Blood vessels; Glycine uptake (Pittaluga, A. (231) 129) (Interaction) (Van Diest, M.J. (231) 267) Glycine uptake Imipramine; Desipramine; Norepinephrine; Triiodothyronine (Suzu- Aging; NMDA receptors; Glycine; D-Cycloserine; Noradrenaline ki, S. (231) 297) release (Pittaluga, A. (231) 129) a-Methyl-5-hydroxytryptamine; Bronchi (rat); 5-HT, receptors; Ke- Gonadotrophin tanserin; Mianserin; Spiperone; Electrical field stimulation; Cholin- Inhibin; Oestradiol-178; Ovarian hormones; Prostaglandin F,,; In- ergic nerves (Szarek, J.L. (231) 339) domethacin (Kogo, H. (231) 481) NMDA (N-methyl-D-aspartate); Cortex; Transmitter interaction GYKI 52466 (1-(4-aminophenyl)-4-methy!-7,8-methylenedioxy-5H- (Rahman, S. (231) 347) 2,3-benzodiazepine - HCI) DBA/2 mice; Aniracetam; AMPA receptor antagonists; NBQX Vascular 5-HT,-like receptors; 5-Carboxamidotryptamine; (Effect of (2,3-dihydroxy-6-nitro-7-sulfamoy)qlubineonxzaloi(neF) ; CPPene pre-contraction) (Choppin, A. (231) 469) (D( — )-(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid) 5-HT motor syndrome (Chapman, A.G. (231) 301) 5-HT |, receptor agonists; 5-HT,, receptor antagonists; 8-OH-DPAT derivatives; (S)-UH-301; LY-41 (Yu, H. (231) 69) Haloperidol Dystonia; Phenobarbital; Dopamine; GABA (y-aminobutyric acid); 5-HT,, receptor agonists Glutamate (Richter, A. (231) 111) 5-HT,, receptor antagonists; 8-OH-DPAT derivatives; (S)-UH-301; LY-41; 5-HT motor syndrome (Yu, H. (231) 69) Paw test; SCH 39166; Raclopride; Dopamine D, receptors; Dopamine D, receptors (Prinssen, E.P.M. (231) 275) -HT,, receptor antagonists -HT,, receptor agonists; 8-OH-DPAT derivatives; (S)-UH-301; LY- o Receptor ligands; Neurogenic twitch contraction; Benzomorphan- 1; 5-HT motor syndrome (Yu, H. (231) 69) type o receptor; ATP transmission; Vas deferens (mouse); Brain (guinea-pig); SK&F 10,047 (N-allylnormetazocine); Rimcazole 5-HT,, receptors (Matsuno, K. (231) 451) Antidepressants; 5-HT (5-hydroxytryptamine, serotonin); 5-HT,,. re- ceptors; (Rat) (Jenck, F. (231) 223) HCO, secretion Nitric oxide (NO); NO synthase inhibitors; L-NAME (N°-nitro-L- Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodopheny!)-2-aminopropane), arginine methyl ester); Duodenum (rat) (Takeuchi, K. (231) 135) 5-HT, receptors; Anxiolysis; Glucose; Corticosterone; Prolactin; Be- haviour (Baudrie, V. (231) 395) Heart cells (embryonic chick) Taurine; Ca?* channels (L-type); Ca?* channels (T-type); Cardiac 5-HT,, /5-HT, receptors myocytes; Voltage clamp (whole cell); Electrophysiology (Satoh, H. Tryptophan; Blood-brain barrier; Sympathetic nervous system; Im- (231) 443) mobilization stress (Chaouloff, F. (231) 77) Heart (dog) 5-HT,< receptors BRL 37344; B,-Adrenoceptors; Chronotropism; Inotropism (Taka- Antidepressants; 5-HT (5-hydroxytryptamine, serotonin); 5-HT,, re- yama, S. (231) 315) ceptors; (Rat) (Jenck, F. (231) 223) Heart (isolated, rat) 5-HT, receptors KRN2391; Cromakalim; Myocardial ischemia; Energy metabolism 5-HT (S-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta- (Ohta, H. (231) 323) mine; Bronchi (rat); Ketanserin; Mianserin; Spiperone; Electrical field stimulation; Cholinergic nerves (Szarek, J.L. (231) 339) Hemodynamics Endothelin-converting enzyme; Big endothelin-1; Big endothelin-3; Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); Phosphoramidon; Endothelin; (Rat) (Pollock, D.M. (231) 459) 5-HT,, receptors; Anxiolysis; Glucose; Corticosterone; Prolactin; Behaviour (Baudrie, V. (231) 395) Hippocampus Somatostatin; 2-Deoxyglucose; Cerebral cortex; Acetylcholine; 5-HT uptake sites Acetylcholine receptors (Shibata, S. (231) 381) Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Cen- thaquin; Blood pressure; Central nervous system (CNS) (Gulati, A GABA , receptors; Coupling mechanism (Potier, B. (231) 427) (231) 151) Hololena curta venom lleum (guinea-pig) w-Conotoxin GVIA; Ca** channels (voltage-sensitive); Funnel web «x-Opioid receptors; Bremazocine; Dynorphin (Webster, J.L. (231) spider toxin; Neurotransmitter release; Autonomic nerves (Lundy, 251) P.M. (231) 197) Imipramine 5-HT (5-hydroxytryptamine, serotonin) Spontaneously hypertensive rat (SHR); Clonidine; Centhaquin; Blood Antidepressants; 5-HT,<. receptors; 5-HT,, receptors; (Rat) (Jenck, pressure; Central nervous system (CNS); 5-HT uptake sites (Gulati, F. (231) 223) A. (231) 151)

ebook img

European Journal of Pharmacology 1993: Vol 231 Index PDF

17 Pages·1993·3.2 MB·English
by  
#periodicals #sim_microfilm #pub_european-journal-pharmacology
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview European Journal of Pharmacology 1993: Vol 231 Index

European Journal of Pharmacology, 231 (1993) 489-492 © 1993 Elsevier Science Publishers B.V. All rights reserved 0014-2999 /93 /$06.00 Author index Al-Zubaidy, Z., see Chapman, A.G. (231) 301 Chaouloff, F., see Baudrie, V. (231) 395 Antunes, E., see Santana, A.C. (231) 237 Chapman, A.G., Al-Zubaidy, Z. and Meldrum, B.S Arimura, A., Asanuma, F., Yagi, H., Kurosawa, A. and Harada, M Aniracetam reverses the anticonvulsant action of NBOX and Involvement of thromboxane A, in bronchial hyperresponsive GYKI 52466 in DBA/2 mice (231) 301 ness but not lung inflammation induced by bacterial lipopolysac Chase, T.N., see Marin, C. (231) 191 charide in guinea pigs (231) 13 Chiba, S., see Takayama, S. (231) 315 Arora, R.C., see Gulati, A. (231) 151 Choppin, A. and O'Connor, S.E. Asanuma, F., see Arimura, A. (231) 13 Pre-contraction with histamine and U46619 unmasks a 5-HT,-like receptor in rabbit renal artery (231) 469 Bai, X., see Walker, J.M. (231) 61 Chovet, M., see Pascaud, X.B. (231) 389 Bakhle, Y.S., see Santana, A.C. (231) 237 Chulia, S., see Ivorra, M.D. (231) 165 Barnes, P.J., see Belvisi, M.G. (231) 97 Chung, K.F., see Sakamoto, T. (231) 31 Barnes, P.J., see Rabe, K.F. (231) 305 Cools, A.R., see Prinssen, E.P.M. (231) 275 Barnes, P.J., see Sakamoto, T. (231) 31 Crayton, J., see Gulati, A. (231) 151 Baudrie, V., De Vry, J., Broqua, P., Schmidt, B., Chaouloff, F. and Glaser, T Damas, J., Remacle-Volon, G. and Bourdon, \ Subchronic treatment with anxiolytic doses of the 5-HT,, recep Platelet-activating factor and the vascular effects of zymosan in tor agonist ipsapirone does not affect 5-HT, receptor sensitivity rats (231) 231 in the rat (231) 395 DeHaven-Hudkins, D.L., see Hudkins, R.L. (231) 485 Baudrie, V., see Chaouloff, F. (231) 77 Del Bianco, E., see Santicioli, P. (231) 139 Bélichard, P., see Pruneau, D. (231) 215 Dent, G., see Rabe, K.F. (231) 305 Belvisi, M.G., Miura, M., Stretton, D. and Barnes, PJ De Nucci, G., see Santana, A.C. (231) 237 Endogenous vasoactive intestinal peptide and nitric oxide modu Dessy, C., Salomone, S., Morel, N. and Godfraind, T late cholinergic neurotransmission in guinea-pig trachea (231) 97 Activity of dihydrothienopyridine $312 enantiomers on L-type Berzetei-Gurske, I.P., see Webster, J.L. (231) 251 Ca** channels in isolated rat aorta and cerebral microvessels Bloss, J.L., see Hammond, D.L. (231) 281 (231) 435 Bond, A., see Boot, J.R. (231) 83 De Vry, J., see Baudrie, V. (231) 395 Boot, J.R., Bond, A., Thomas, K.H., O’Brien, A., Gilmore, J. and Diana, M., see Rossetti, Z.L. (231) 203 Todd, A Divish, B.J., see Pollock, D.M. (231) 459 The pharmacology of LY290324 in the guinea-pig: an orally D’Ocon, M.P., see Ivorra, M.D. (231) 165 active, potent and selective cysteiny! leukotriene receptor antago Dolata, J., see Lindberg, S. (231) 375 nist (231) 83 Dutar, P., see Potier, B. (231) 427 Bot, G. and Chahl, L.A Effects of pertussis toxin on behavioural responses of guinea-pigs Ellenbroek, B.A., see Prinssen, E.P.M. (231) 275 to centrally administered substance P, quinpirole, carbachol, | Evans, P., see Rabe, K.F. (231) 305 50,488H, morphine and morphine withdrawal (231) 53 Bourdon, V., see Damas, J. (231) 231 Fedele, E., see Pittaluga, A. (231) 129 Bowen, W.D., see Walker, J.M. (231) 61 Ferrer, J.M.R., Sabater, R. and Saez, J.A Brandt, S.R., see Webster, J.L. (231) 251 Neurotensin participates in self-stimulation of the medial pre Brédemann, R., see Krug, M. (231) 355 frontal cortex in the rat (231) 39 Broqua, P., see Baudrie, V. (231) 395 Frew, R., see Lundy, P.M. (231) 197 Burres, N.S., see Pollock, D.M. (231) 459 Fride, E. and Mechoulam, R Pharmacological activity of the cannabinoid receptor agonist, Calignano, A., Persico, P., Mancuso, F. and Sorrentino, | anandamide, a brain constituent (231) 313 Endogenous nitric oxide modulates morphine-induced changes in Fu, W.-M., see Liu, S.-H. (231) 23 locomotion and food intake in mice (231) 415 Fujisawa, A., see Shimamura, K. (231) 103 Capogna, M., see Zeise, M.L. (231) 47 Fukutake, K., see Mizuguchi, K. (231) 121 Carroll, F.1., see Walker, J.M. (231) 61 Furukawa, Y., see Takayama, S. (231) 315 Chahl, L.A., see Bot, G. (231) 53 Chan, P., Li, Y., Zheng, Z., Hu, P., Sarbach, $S.D. and Guez, D Gaudry-Talarmain, Y.M., see Moulian, N. (231) 407 Neurologic and histologic evaluation of almitrine + raubasine Gessa, G.L., see Rossetti, Z.L. (231) 203 (Duxil”) in middle cerebral artery occlusion in cats (231) 175 Giembycz, M.A., see Rabe, K.F. (231) 305 Chaouloff, F., Layeillon, C. and Baudrie, V Gilmore, J., see Boot, J.R. (231) 83 5-HT,,-/5-HT, receptor blockade prevents 1-(2,5-dimethoxy-4 Glaser, T., see Baudrie, V. (231) 395 iodopheny!)2-aminopropane-, but not stress-induced increases in Godfraind, T., see Dessy, C. (231) 435 brain tryptophan (231) 77 Gruetter, C.A., see Szarek, J.L. (231) 339 490 Guez, D., see Chan, P. (231) 175 Kobayashi, A., see Suzuki, S. (231) 297 Gulati, A., Arora, R.C. and Crayton, J Koga, Y., see Shibata, S. (231) 381 Central serotonergic uptake mechanisms in hypertensive rats Kogo, H., Takasaki, K., Takeo, S., Watanabe, G., Taya, K. and effects of clonidine and centhaquin (231) 151 Sasamoto, S A role of prostaglandin in the secretion of inhibin and oestradiol- Hacksell, U., see Yu, H. (231) 69 17B in equine chorionic gonadotrophin-primed rats (231) 481 Haefely, W.E., see Jenck, F. (231) 223 Krug, M., Matthies, R., Wagner, M. and Brodemann, R Hamada, T., see Shibata, S. (231) 381 Non-opioid antitussives and methadone differentially influence Hammond, D.L. and Bloss, J.1 hippocampal long-term potentiation in freely moving rats (231) Antinociceptive effects of SC-39566, an opioid dipeptide arylal- 355 kylamide, in the Rhesus monkey (231) 281 Kuribara, H Harada, K., see Ohta, H. (231) 323 Ceruletide, a cholecystokinin-like decapeptide, differentially re- Harada, M., see Arimura, A. (231) 13 duces the stimulant effect of MK-801 and ketamine: evaluation Haruno, A., see Matsuzaki, T. (231) 363 by discrete shuttle avoidance in mice (231) 7 Hashimoto, K., see Matsuzaki, T. (231) 363 Kurosawa, A., see Arimura, A. (231) 13 Hashimoto, S., Kigoshi, S. and Muramatsu, | Nitric oxide-dependent and -independent neurogenic relaxation Labie, C., Keane, P.E., Soubrié, P. and Le Fur, G of isolated dog urethra (231) 209 The o receptor ligand SR 31742A increases neurotensin in the Herman, A.G., see Van Diest, M.J. (231) 267 nucleus accumbens but not in the caudate-putamen of the rat Hirata, Y., Takiguchi, Y., Wada, K., Matsuno, H., Umemura, K., (231) 465 Uematsu, T. and Nakashima, M Layeillon, C., see Chaouloff, F. (231) 77 Roles of platelet-activating factor, thromboxane A,, ADP and Lé, A.D., see Wu, P.H. (231) 157 thrombin in thrombogenesis in the guinea pig (231) 421 Le Fur, G., see Labie, C. (231) 465 Hmaidan, Y., see Rossetti, Z.L. (231) 203 Lehmkuhl, A., see Hoey, A. (231) 477 Hoey, A., Lehmkuhl, A., Sadony, V. and Ravens, U Lemaire, S., see Shukla, V.K. (231) 293 Inotropic actions of BDF 9148 and DPI 201-106 and their enan Lewander, T., see Yu, H. (231) 69 tiomers in guinea-pig, rat and human atria (231) 477 Li, Y., see Chan, P. (231) 175 Hong, K.W., Park, M.G., Shin, Y.W., Rhim, B.Y. and Ko, K.H Lindberg, S. and Dolata, J Effect of ouabain on relaxation induced by cromakalim in human NK, receptors mediate the increase in mucociliary activity pro and canine mesenteric arteries (231) 1 duced by tachykinins (231) 375 Hori, M., see Karaki, H. (231) 371 Lin-Shiau, S.-Y., see Liu, $.-H. (231) 23 Hu, P., see Chan, P. (231) 175 Liu, G.J. and Takeuchi, H Huang, K.-X., see Sun, B.-C. (231) 331 AJ-2615, a long-acting Ca** channel antagonist with a novel Hudkins, R.L., Stubbins, J.F. and DeHaven-Hudkins, D.L. structure (231) 91 Caramiphen, iodocaramiphen and nitrocaramiphen are potent, Liu, J.-F., see Wu, P.H. (231) 157 competitive, muscarinic M, receptor-selective agents (231) 485 Liu, S.-H., Fu, W.-M. and Lin-Shiau, S.-Y Hudson, G.M., see Young, G.A. (231) 473 Studies on the inhibition by chlorpromazine of myotonia induced Hyslop, S., see Santana, A.C. (231) 237 by ion channel modulators in mouse skeletal muscle (231) 23 Liu, Y., see Yu, H. (231) 69 Inoue, Y., see Takayama, S. (231) 315 Lockwood, M., see Patrick, $.L. (231) 243 Ishibashi, M., see Mizuguchi, K. (231) 121 Loh, H.H., see Tao, P.-L. (231) 145 Israél, M., see Moulian, N. (231) 407 Léscher, W., see Richter, A. (231) 111 Ivorra, M.D., Chulia, S., Lugnier, C. and D’Ocon, M.P Léscher, W., see Richter, A. (231) 287 Selective action of two aporphines at a,-adrenoceptors and po- Léschmann, P.-A., see Richter, A. (231) 287 tential-operated Ca?* channels (231) 165 Lugnier, C., see Ivorra, M.D. (231) 165 Lundy, P.M. and Frew, R Jenck, F., Moreau, J.-L., Mutel, V., Martin, J.R. and Haefely, W.E Pharmacological characterization of voltage-sensitive Ca~* chan Evidence for a role of 5-HT,. receptors in the antiserotonergic nels in autonomic nerves (231) 197 properties of some antidepressant drugs (231) 223 Jin, G.-Z., see Sun, B.-C. (231) 331 Maggi, C.A., see Santicioli, P. (231) 139 Jinno, Y., see Ohta, H. (231) 323 Mancuso, F., see Calignano, A. (231) 415 Junien, J.-L., see Pascaud, X.B. (231) 389 Marin, C. and Chase, T.N Jun Liu, G. and Takeuchi, H Dopamine D, receptor stimulation but not dopamine D, recep Modulatory effects of achatin-l, an Achatina endogenous neu tor stimulation attenuates haloperidol-induced behavioral super- roactive peptide, on responses to 5-hydroxytryptamine (231) 259 sensitivity and receptor up-regulation (231) 191 Martin, J.R., see Jenck, F. (231) 223 Kalan, H., see Wu, P.H. (231) 157 Masada, A., see Mizuguchi, K. (231) 121 Kameyama, T., see Ukai, M. (231) 143 Mascarella, $.W., see Walker, J.M. (231) 61 Karaki, H., Sudjarwo, S.A., Hori, M., Sakata, K., Urade, Y., Takai, Matsuno, H., see Hirata, Y. (231) 421 M. and Okada, T Matsuno, K., Senda, T. and Mita, S ET, receptor antagonist, IRL 1038, selectively inhibits the en- Correlation between potentiation of neurogenic twitch contrac- dothelin-induced endothelium-dependent vascular relaxation tion and benzomorphan o receptor binding potency in the mouse (231) 371 vas deferens (231) 451 Kasparov, S., see Zeise, M.L. (231) 47 Matsuzaki, T., Haruno, A. and Hashimoto, K. Keane, P.E., see Labie, C. (231) 465 Effects of gallopamil, a Ca?* channel blocker in models of Kigoshi, S., see Hashimoto, S. (231) 209 ventricular arrhythmia in dogs (231) 363 Ko, K.H., see Hong, K.W. (231) 1 Matthies, R., see Krug, M. (231) 355 491 McAllister, K.H In vivo characterization of a phosphoramidon-sensitive endothe- Antagonism of non-NMDA receptors inhibits handling-induced, lin-converting enzyme in the rat (231) 459 strychnine-potentiated convulsions (231) 309 Potier, B. and Dutar, P Mechoulam, R., see Fride, E. (231) 313 Presynaptic inhibitory effect of baclofen on hippocampal in- Meldrum, B.S., see Chapman, A.G. (231) 301 hibitory synaptic transmission involves a pertussis toxin-sensitive Mihic, S.J., see Wu, P.H. (231) 157 G-protein (231) 427 Milicic, 1., see Pollock, D.M. (231) 459 Prinssen, E.P.M., Ellenbroek, B.A., Stamatovic, B. and Cools, A.R Mita, S., see Matsuno, K. (231) 451 The effects of haloperidol and raclopride in the paw test are Miura, M., see Belvisi, M.G. (231) 97 influenced similarly by SCH 39166 (231) 275 Miwa, A., see Ohta, H. (231) 323 Pruneau, D. and Bélichard, P Miyake, H., see Takeuchi, K. (231) 135 Endothelium-dependent control of vascular tone in the rabbit Mizota, M., see Mizuguchi, K. (231) 121 kidney after ischemia and reperfusion (231) 215 Mizuguchi, K., Yano, T., Tanaka, Y., Ishibashi, M., Masada, A Mizota, M., Fukutake, K. and Saito, Y Rabe, K.F., Giembycz, M.A., Dent, G., Perkins, R.S., Evans, P. and Mechanism of the lipid-lowering effect of ethyl all-cis Barnes, PJ 5,8,11,14,17-icosapentaenoate (231) 121 Salmeterol is a competitive antagonist at B-adrenoceptors medi Moreau, J.-L., see Jenck, F. (231) 223 ating inhibition of respiratory burst in guinea-pig eosinophils Morel, N., see Dessy, C. (231) 435 (231) 305 Mori, E., see Ukai, M. (231) 143 Rahman, S. and Neuman, R.S Moulian, N., Gaudry-Talarmain, Y.M. and Israél, M Activation of 5-HT, receptors facilitates depolarization of neo- The effect of MR16728, a cetiedil analogue, on acetylcholine cortical neurons by N-methyl-D-aspartate (231) 347 release in Torpedo synaptosomes (231) 407 Raiteri, M., see Pittaluga, A. (231) 129 Muramatsu, I., see Hashimoto, S. (231) 209 Ravens, U., see Hoey, A. (231) 477 Mutel, V., see Jenck, F. (231) 223 Remacle-Volon, G., see Damas, J. (231) 231 Ren, L.-M., see Takayama, S. (231) 315 Nakashima, M., see Hirata, Y. (231) 421 Rhim, B.Y., see Hong, K.W. (231) 1 Nakazawa, H., see Ohta, H. (231) 323 Richter, A. and Léscher, W Nakazawa, K., see Suzuki, S. (231) 297 Alterations in pharmacological sensitivity of GABAergic but not Neuman, R.S., see Rahman, S. (231) 347 dopaminergic and glutamatergic systems during ontogenesis in Niki, S., see Takeuchi, K. (231) 135 dystonic mutant hamsters (231) 111 Nishikori, K., see Ohta, H. (231) 323 Richter, A., Léscher, W. and Léschmann, P.-A Novosad, E.1., see Pollock, D.M. (231) 459 The AMPA receptor antagonist NBOX exerts antidystonic ef- fects in an animal model of idiopathic dystonia (231) 287 O’Brien, A., see Boot, J.R. (231) 83 O'Connor, S.E., see Choppin, A. (231) 469 Risiglione, C., see Pittaluga, A. (231) 129 Ogawa, N., see Ohta, H. (231) 323 Rossetti, Z.L., Hmaidan, Y., Diana, M. and Gessa, G.I Ohta, H., Nakazawa, H., Jinno, Y., Harada, K., Ogawa, N., Miwa, A Lack of tolerance to ethanol-induced dopamine release in the rat and Nishikori, K ventral striatum (231) 203 Effects of K* channel openers on ischemic dysfunction and Roze, C., see Pascaud, X.B. (231) 389 metabolic disturbance in isolated perfused rat heart (231) 323 Sabater, R., see Ferrer, J.M.R. (231) 39 Ohuchi, T., see Takeuchi, K. (231) 135 Okabe, S., see Takeuchi, K. (231) 135 Sadony, V., see Hoey, A. (231) 477 Okada, T., see Karaki, H. (231) 371 Saez, J.A., see Ferrer, J.M.R. (231) 39 Opgenorth, T.J., see Pollock, D.M. (231) 459 Saito, Y., see Mizuguchi, K. (231) 121 Orito, K., Satoh, K. and Taira, N Sakamoto, T., Barnes, PJ. and Chung, K.F Involvement of ATP-sensitive K* channels in the sustained coro Effect of CP-96,345, a non-peptide NK, receptor antagonist, nary vasodilator response to adenosine in dogs (231) 183 against substance P-, bradykinin- and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig Park, M.G., see Hong, K.W. (231) 1 (231) 31 Pascaud, X.B., Chovet, M., Roze, C. and Junien, J.-1 Sakata, K., see Karaki, H. (231) 371 Neuropeptide Y and o receptor agonists act through a common Salomone, S., see Dessy, C. (231) 435 pathway to stimulate duodenal alkaline secretion in rats (231) 389 Santana, A.C., Hyslop, S., Antunes, E., De Nucci, G. and Bakhle, Patrick, R.L., see Patrick, $.L. (231) 243 YS Patrick, S.L., Walker, J.M., Perkel, J.M., Lockwood, M. and Patrick Anti-inflammatory activities of Ph CL28A in rats in vivo (231) 237 R.1 Santicioli, P., Del Bianco, E. and Maggi, C.A Increases in rat striatal extracellular dopamine and vacuous Adenosine A, receptors mediate the presynaptic inhibition of chewing produced by two o receptor ligands (231) 243 calcitonin gene-related peptide release by adenosine in the rat Patrick, S.L., see Walker, J.M. (231) 61 spinal cord (231) 139 Perkel, J.M., see Patrick, S.L. (231) 243 Sarbach, S.D., see Chan, P. (231) 175 Perkins, R.S., see Rabe, K.F. (231) 305 Sasamoto, S., see Kogo, H. (231) 481 Persico, P., see Calignano, A. (231) 415 Satoh, H. and Sperelakis, N Pittaluga, A., Fedele, E., Risiglione, C. and Raiteri, M Effects of taurine on Ca** currents in young embryonic chick Age-related decrease of the NMDA receptor-mediated nor cardiomyocytes (231) 443 adrenaline release in rat hippocampus and partial restoration by Satoh, K., see Orito, K. (231) 183 D-cycloserine (231) 129 Sawaki, S., see Takayama, S. (231) 315 Polgar, W.E., see Webster, J.L. (231) 251 Schmidt, B., see Baudrie, V. (231) 395 Pollock, D.M., Divish, B.J., Milicic, 1., Novosad, E.1., Burres, N.S Senda, T., see Matsuno, K. (231) 451 and Opgenorth, T.J Seybold, V.S., see Tao, P.-L. (231) 145 492 Shibata, S., Koga, Y., Hamada, T. and Watanabe, S$ Taya, K., see Kogo, H. (231) 481 Facilitation of 2-deoxyglucose uptake in rat cortex and hippocam Thomas, K.H., see Boot, J.R. (231) 83 pus slices by somatostatin is independent of cholinergic activity Toda, N., see Shimamura, K. (231) 103 (231) 381 Todd, A., see Boot, J.R. (231) 83 Shimamura, K., Fujisawa, A., Toda, N. and Sunano, S Toll, L., see Webster, J.L. (231) 251 Effects of N“-nitro-L-arginine on electrical and mechanical re sponses to stimulation of non-adrenergic, non-cholinergic in Uematsu, T., see Hirata, Y. (231) 421 hibitory nerves in circular muscle of the rat gastric fundus (231) Ukai, M., Mori, E. and Kameyama, T 103 Cocaine-like discriminative stimulus properties of the 6-selective Shin, Y.W., see Hong, K.W. (231) 1 opioid receptor agonist, [D-Pen*,L-Pen* Jenkephalin, in the rat Shukla, V.K. and Lemaire, S (231) 143 Norbinaltorphimine protection against N-methyl-D-aspartic Umemura, K., see Hirata, Y. (231) 421 acid-induced convulsions and mortality (231) 293 Urade, Y., see Karaki, H. (231) 371 Sorrentino, L., see Calignano, A. (231) 415 Soubrié, P., see Labie, C. (231) 465 Van Diest, M.J., Verbeuren, T.J. and Herman, A.G Sperelakis, N., see Satoh, H. (231) 443 Vascular interaction between 5-hydroxytryptamine and Stamatovic, B., see Prinssen, E.P.M. (231) 275 oxygenase metabolites of arachidonic acid (231) 267 Stamidis, H., see Young, G.A. (231) 473 Verbeuren, T.J., see Van Diest, M.J. (231) 267 Steinfels, G.F., see Young, G.A. (231) 473 Stretton, D., see Belvisi, M.G. (231) 97 Wada, K., see Hirata, Y. (231) 421 Stubbins, J.F., see Hudkins, R.L. (231) 485 Wagner, M., see Krug, M. (231) 355 Sudjarwo, S.A., see Karaki, H. (231) 371 Walker, J.M., Bowen, W.D., Patrick, S.I Williams, W.E., Mas Sugita, S., see Suzuki, S. (231) 297 carella, $.W., Bai, X. and Carroll, F.1 Sun, B.-C., Huang, K.-X. and Jin, G.-Z A comparison of (— )-deoxybenzomorphans devoid of opiate ac Repeated reserpine treatment alters firing pattern and responses tivity with their dextrorotatory phenolic counterparts suggests of substantia nigral dopamine neurons (231) 331 role of a) receptors in motor function (231) 61 Sunano, S., see Shimamura, K. (231) 103 Walker, J.M., see Patrick, S.L. (231) 243 Suzuki, S., Yoshida, T., Sugita, $., Kobayashi, A. and Nakazawa, K Watanabe, G., see Kogo, H. (231) 481 Triiodothyronine increases desipramine with changing the con Watanabe, S., see Shibata, S. (231) 381 centrations of monoamines, in the brain of rat given imipramine Webster, J.L., Polgar, W.E., Brandt, S$.R., Berzetei-Gurske, 1.P. and (231) 297 Toll, I Szarek, J.L., Zhang, J.Z. and Gruetter, C.A Comparison of «,-opioid receptors in guinea pig brain and guinea 5-HT, receptors augment cholinergic nerve-mediated contraction pig ileum membranes (231) 251 of rat bronchi (231) 339 Williams, W.E., see Walker, J.M. (231) 61 Wu, P.H., Mihic, S.J., Liu, J.-F., Lé, A.D. and Kalan, H Taira, N., see Orito, K. (231) 183 Blockade of chronic tolerance to ethanol by the NMDA antago Takai, M., see Karaki, H. (231) 371 nist, (+ )}-MK-801 (231) 157 Takasaki, K., see Kogo, H. (231) 481 Takayama, S., Furukawa, Y., Ren, L.-M., Inoue, Y., Sawaki, S. and Yagi, H., see Arimura, A. (231) 13 Chiba, S$ Yano, T., see Mizuguchi, K. (231) 121 Positive chronotropic and inotropic responses to BRL 37344, a Yoshida, T., see Suzuki, S. (231) 297 B,-adrenoceptor agonist in isolated, blood-perfused dog atria Young, G.A., Hudson, G.M., Stamidis, H. and Steinfels, G.I (231) 315 Interactions between U-50,488H and o receptor antagonists Takeo, S., see Kogo, H. (231) 481 EEG, EEG power spectral and behavioral correlates (231) 473 Takeuchi, H., see Jun Liu, G. (231) 259 Yu, H., Liu, Y., Hacksell, U. and Lewander, T Takeuchi, H., see Liu, G.J. (231) 91 (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel Takeuchi, K., Ohuchi, T., Miyake, H., Niki, S. and Okabe, S 5-HT,, receptor agonists (231) 69 Effects of nitric oxide synthase inhibitors on duodenal alkaline secretion in anesthetized rats (231) 135 Zeise, M.L., Kasparov, S., Capogna, M. and Zieglgansberger, W Takiguchi, Y., see Hirata, Y. (231) 421 Acamprosate (calciumacetylhomotaurinate) decreases postsynap Tanaka, Y., see Mizuguchi, K. (231) 121 tic potentials in the rat neocortex: possible involvement of excita Tao, P.-L., Seybold, V.S. and Loh, H.H tory amino acid receptors (231) 47 Autoradiographic evidence for decrease in binding of u- and Zhang, J.Z., see Szarek, J.L. (231) 339 5-opioid receptors after subchronic [D-Ala*,D-Leu* Jenkephalin Zheng, Z., see Chan, P. (231) 175 treatment in rats (231) 145 Zieglgansberger, W., see Zeise, M.L. (231) 47 European Journal of Pharmacology, 231 (1993) 493-504 © 1993 Elsevier Science Publishers B.V. All rights reserved 0014-2999 /93 /$06.00 Key word index Acamprosate (calciumacetylhomotaurinate ) Airway microvascular leakage Excitatory amino acids; GABA (y-aminobutyric acid); Neocortex Allergen; Bradykinin; CP-96,345; NK receptors; Substance P Postsynaptic potentials; Neurotransmission (Zeise, M.L. (231) 47) (Sakamoto, T. (231) 31) Acetylcholine AJ-2615 Somatostatin; 2-Deoxyglucose; Cerebral cortex; Hippocampus Ca channel antagonists; lon channels; (Neurons), (Snail) (Liu, Acetylcholine receptors (Shibata, S$. (231) 381) G.J. (231) 91) Acetylcholine receptors Allergen Somatostatin; 2-Deoxyglucose; Cerebral cortex; Hippocampus Bradykinin; CP-96,345; Airway microvascular leakage; NK, recep Acetylcholine (Shibata, S. (231) 381) tors; Substance P (Sakamoto, T. (231) 31) Acetylcholine release Almitrine Ca**; Cetiedil; Cholinergic synapses; Mediatophore; (Torpedo mar Raubasine; Middle cerebral artery; Ischemia; Penumbra; (Cat) (Chan morata synaptosomes) (Moulian, N. (231) 407) P. (231) 175) Achatin-1 D-Amino acid residue D-Amino acid residue; Molluscan peptide; 5-HT (5-hydroxytrypta Achatin-Il; Molluscan peptide; 5-HT (5-hydroxytryptamine, sero mine, serotonin); Modulatory effects; Voltage clamp; Neurons; (Snail) tonin); Modulatory effects; Voltage clamp; Neurons; (Snail) Jun Liu, (Jun Liu, G. (231) 259) G. (231) 259) Adenosine AMPA (a@-amino-3-hydroxy-5-methyl-4-isoxazole propionate) Norbinaltorphimine; NMDA (N-methyl-D-aspartate),; Convulsion; Antinociception; Adenosine receptors; Sensory neuropeptides; Cap Mortality (Shukla, V.K. (231) 293) saicin (Santicioli, P. (231) 139) AMPA receptor antagonists Adenosine A receptor-mediated vasodilatation; K channels DBA/2 mice Aniracetam; NBOX (2,3-dihydroxy-6-nitro-7 (ATP-sensitive); 8-Phenyltheophylline; Glibenclamide (Orito, K sulfamoylbenzo(F )quinoxaline); GYKI 52466 (144-aminophenyl)-4 (231) 183) methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine -H Cl); CPPene (D( — )}( E)-4-3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid) Adenosine A, receptor-mediated vasodilatation (Chapman, A.G. (231) 301) Adenosine; K channels (ATP-sensitive), 8-Phenyltheophylline Glibenclamide (Orito, K. (231) 183) Aniracetam DBA/2 mice; AMPA receptor antagonists; NBOX (2,3-dihydroxy Adenosine receptors 6-nitro-7-sulfamoylbenzo(F )quinoxaline); GYKI 52466 (1-44 Adenosine; Antinociception; Sensory neuropeptides; Capsaicin aminopheny|)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine (Santicioli, P. (231) 139) HCl); CPPene (D(— )4E)-4-43-phosphonoprop-2-enyl) piperazine-2 carboxylic acid) (Chapman, A.G. (231) 301) ADP Thrombosis; Thromboxane A PAF (platelet-activating factor Antidepressants PAF-acether), Thrombin; (Guinea-pig) (Hirata, Y. (231) 421) 5-HT (S-hydroxytryptamine, serotonin); 5-HT,,. receptors; 5-HT A receptors; (Rat) (Jenck, F. (231) 223) a ,-Adrenoceptor antagonists Ca channel antagonists; Aorta (rat); Aporphines; Phosphodi Antinociception esterase inhibitors (Ivorra, M.D. (231) 165) Adenosine; Adenosine receptors; Sensory neuropeptides; Capsaicin (Santicioli, P. (231) 139) 8 -Adrenoceptors Eosinophils; Respiratory burst; Salmeterol; Eformoterol; Salbutamol Shock titration; Opioid peptides; Rhesus monkey; SC-39566 (Ham (Rabe, K.F. (231) 305) mond, D.L. (231) 281) B ,-Adrenoceptors Antipsychotics BRL 37344; Chronotropism; Inotropism; Heart (dog) (Takayama, S SR 31742A; Neurotensin; o Receptor ligands (Labie, C. (231) 465) (231) 315) Anxiolysis Aging Ipsapirone; DOI (1-2,5-dimethoxy-4-iodophenyl )-2-aminopropane) NMDA receptors; Glycine; D-Cycloserine; Noradrenaline release 5-HT,, receptors; 5-HT, receptors; Glucose; Corticosterone; Pro Glycine uptake (Pittaluga, A. (231) 129) lactin; Behaviour (Baudrie, V. (231) 395) 494 Aorta (rat) Big endothelin-3 Ca?* channel antagonists; a,-Adrenoceptor antagonists; Apor- Endothelin-converting enzyme; Big endothelin-1; Phosphoramidon; phines; Phosphodiesterase inhibitors (Ivorra, M.D. (231) 165) Endothelin; Hemodynamics; (Rat) (Pollock, D.M. (231) 459) Smooth muscle (vascular); Endothelium (vascular); EDRF (endo- Blood-brain barrier thelium-derived relaxing factor); Endothelins; ET, receptors; ET, Tryptophan; 5-HT,,.. /5-HT, receptors; Sympathetic nervous system; receptor antagonists; IRL 1038 (Karaki, H. (231) 371) Immobilization stress (Chaouloff, F. (231) 77) $312; Dihydrothienopyridine; Cerebral microvessels (rat); Dihy- Blood pressure dropyridine binding site; Phenylalkylamine binding site (Dessy, C Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Cen- (231) 435) thaquin; Central nervous system (CNS); 5-HT uptake sites (Gulati, A. (231) 151) Aporphines Ca** channel antagonists; a,-Adrenoceptor antagonists; Aorta (rat); Blood vessels Phosphodiesterase inhibitors (Ivorra, M.D. (231) 165) Contractions; 5-HT (5-hydroxytryptamine, serotonin); Lipoxygenase products; Atherosclerosis; (Interaction) (Van Diest, M.J. (231) 267) Atherosclerosis Contractions; 5-HT (S-hydroxytryptamine, serotonin); Lipoxygenase Bradykinin products; Blood vessels; (Interaction) (Van Diest, M.J. (231) 267) Allergen; CP-96,345; Airway microvascular leakage; NK, receptors; Substance P (Sakamoto, T. (231) 31) ATP transmission o Receptor ligands; Neurogenic twitch contraction; Benzomorphan- Brain (guinea-pig) type o receptor; Vas deferens (mouse); Brain (guinea-pig); SK&F oa Receptor ligands; Neurogenic twitch contraction; Benzomorphan- 10,047 (N-allylnormetazocine); Rimcazole; Haloperidol (Matsuno, K type o receptor; ATP transmission; Vas deferens (mouse); SK&F (231) 451) 10,047 (N-allylnormetazocine); Rimcazole; Haloperidol (Matsuno, K (231) 451) Autonomic nerves w-Conotoxin GVIA; Ca’* channels (voltage-sensitive); Hololena Bremazocine curta venom; Funnel web spider toxin; Neurotransmitter release «-Opioid receptors; Dynorphin; Ileum (guinea-pig) (Webster, J.1 (Lundy, P.M. (231) 197) (231) 251) Autoradiography BRL 37344 Tolerance; DADLE ({D-Ala?,D-Leu* Jenkephalin); Opioid receptors; B,-Adrenoceptors; Chronotropism; Inotropism; Heart (dog) (Rat) (Tao, P.-L. (231) 145) (Takayama, S. (231) 315) Dopamine receptors; Stereotypies; Behavioral supersensitivity (Marin, C. (231) 191) Bronchial hyperresponsiveness $-1452 (calcium (1R,2S,3S,4S)-(5Z)-7-(((phenylsulfonyl)amino)bi cyclo[2.2.1}hept-2-yDhept-5-enoate dihydrate); Thromboxane A,; Avoidance behaviour Lipopolysaccharide; TNF (tumor necrosis factor) (Arimura, A. (231) MK-801; Ketamine; Methamphetamine; Ceruletide; Cholecys- tokinin-like decapeptide; Dopamine release (Kuribara, H. (231) 7) 13) Bronchi (rat) BDF 9148 DPI 201-106; Positive inotropy; (Enantiomers) (Hoey, A. (231) 477) 5-HT (S-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta mine; 5-HT, receptors; Ketanserin; Mianserin; Spiperone; Electrical field stimulation; Cholinergic nerves (Szarek, J.L. (231) 339) Behavioral supersensitivity Dopamine receptors; Stereotypies; Autoradiography (Marin, C. (231) Ca** 191) Acetylcholine release; Cetiedil; Cholinergic synapses; Mediatophore; Behaviour (Torpedo marmorata synaptosomes) (Moulian, N. (231) 407) Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Glucose; Corticos- Ca** channel antagonists terone; Prolactin (Baudrie, V. (231) 395) AJ-2615; lon channels; (Neurons); (Snail) (Liu, G.J. (231) 91) Benzomorphan-type o receptor a,-Adrenoceptor antagonists; Aorta (rat); Aporphines; Phosphodi- oa Receptor ligands; Neurogenic twitch contraction; ATP transmis esterase inhibitors (Ivorra, M.D. (231) 165) sion; Vas deferens (mouse); Brain (guinea-pig); SK&F 10,047 (N-al- lylinormetazocine); Rimcazole; Haloperidol (Matsuno, K. (231) 451) Ca** channels (L-type) Taurine; Ca** channels (T-type); Cardiac myocytes; Heart cells Bicarbonate secretion (embryonic chick); Voltage clamp (whole cell); Electrophysiology Neuropeptide Y (NPY); a Receptors; CCK (cholecystokinin); Duo- (Satoh, H. (231) 443) denum; (Rat) (Pascaud, X.B. (231) 389) Ca** channels (T-type) Big endothelin-1 Taurine; Ca** channels (L-type); Cardiac myocytes; Heart cells Endothelin-converting enzyme; Big endothelin-3; Phosphoramidon; (embryonic chick); Voltage clamp (whole cell); Electrophysiology Endothelin; Hemodynamics; (Rat) (Pollock, D.M. (231) 459) (Satoh, H. (231) 443) Ca** channels (voltage-sensitive) Cholecystokinin-like decapeptide w-Conotoxin GVIA; Hololena curta venom; Funnel web spider toxin; MK-801; Ketamine; Methamphetamine; Ceruletide; Dopamine re- Neurotransmitter release; Autonomic nerves (Lundy, P.M. (231) 197) lease; Avoidance behaviour (Kuribara, H. (231) 7) Cannabinoids Cholesterol metabolism Tetrahydrocannabinol; Marihuana (Fride, E. (231) 313) EPA-E (ethyl all-cis-5,8,11,14,17-icosapentaenoate); (Rat) (Mizu- guchi, K. (231) 121) Capsaicin Adenosine; Antinociception; Adenosine receptors; Sensory neu- Cholinergic nerves ropeptides (Santicioli, P. (231) 139) 5-HT (5-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta mine; Bronchi (rat); 5-HT, receptors; Ketanserin; Mianserin; Spiper- Caramiphen one; Electrical field stimulation (Szarek, J.L. (231) 339) lodocaramiphen; Nitrocaramiphen: Muscarinic receptor antagonists; Muscarinic M, receptors; (Rat) (Hudkins, R.L. (231) 485) Cholinergic neurotransmission VIP (vasoactive intestinal polypeptide); Nitric oxide (NO); Inhibitory Carbachol non-adrenergic non-cholinergic (i-NANC); Electrical field stimula- Pertussis toxin; Morphine; Substance P; Quinpirole; U-50,488H (Bot, tion (Belvisi, M.G. (231) 97) G. (231) 53) Cholinergic synapses 5-Carboxamidotryptamine Acetylcholine release; Ca? *; Cetiedil; Mediatophore; (Torpedo mar- Vascular 5-HT,-like receptors; 5-HT (S-hydroxytryptamine, sero morata synaptosomes) (Moulian, N. (231) 407) tonin); (Effect of pre-contraction) (Choppin, A. (231) 469) Chronotropism Cardiac myocytes BRL 37344; 8,-Adrenoceptors; Inotropism; Heart (dog) (Takayama, Taurine; Ca** channels (L-type); Ca** channels (T-type); Heart S. (231) 315) cells (embryonic chick); Voltage clamp (whole cell); Electrophysiol ogy (Satoh, H. (231) 443) Cilia Maxillary sinus; Mucociliary activity; Phosphoramidon; Tachykinins; Carrageenan Tachykinin receptors; (Rabbit) (Lindberg, S. (231) 375) Oedema; Ph CL28A; Pleurisy; Prostacyclin; Thromboxane (Santana, A.C, (231) 237) Clonidine Spontaneously hypertensive rat (SHR); Imipramine; Centhaquin; CCK (cholecystokinin) Blood pressure; Central nervous system (CNS); 5-HT uptake sites Neuropeptide Y (NPY); o Receptors; Bicarbonate secretion; Duo (Gulati, A. (231) 151) denum; (Rat) (Pascaud, X.B. (231) 389) Cocaine Centhaquin [D-Pen?,I -Pen” Jenkephalin; Naltrindole (Ukai, M. (231) 143) Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Blood pressure; Central nervous system (CNS); 5-HT uptake sites (Gulati, Codeine A. (231) 151) Dentate gyrus; Field potentials; Long-term potentiation; NMDA receptors; Dextromethorphan; Methadone; Normethadone; MK 801 Central nervous system (CNS) (Krug, M. (231) 355) Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Cen thaquin; Blood pressure; 5-HT uptake sites (Gulati, A. (231) 151) Complement Zymosan; PAF (platelet-activating factor, PAF-acether); WEB 2086 Cerebral cortex SM-12502; Plasma leakage (Damas, J. (231) 231) Somatostatin; 2-Deoxyglucose; Hippocampus; Acetylcholine; Acetyl- choline receptors (Shibata, S. (231) 381) w-Conotoxin GVIA Ca** channels (voltage-sensitive); Hololena curta venom; Funnel Cerebral microvessels (rat) web spider toxin; Neurotransmitter release; Autonomic nerves $312; Dihydrothienopyridine; Aorta (rat); Dihydropyridine binding (Lundy, P.M. (231) 197) site; Phenylalkylamine binding site (Dessy, C. (231) 435) Contractions Ceruletide 5-HT (5-hydroxytryptamine, serotonin); Lipoxygenase products; MK-801; Ketamine; Methamphetamine; Cholecystokinin-like de- Atherosclerosis; Blood vessels; (Interaction) (Van Diest, M.J. (231) capeptide; Dopamine release; Avoidance behaviour (Kuribara, H 267) (231) 7) Convulsion Cetiedil Norbinaltorphimine; NMDA _ (N-methyl-D-aspartate); AMPA Acetylcholine release; Ca**; Cholinergic synapses; Mediatophore; (a-amino-3-hydroxy-5-methyl-4-isoxazole propionate); Mortality (Torpedo marmorata synaptosomes) (Moulian, N. (231) 407) (Shukla, V.K. (231) 293) Chlorpromazine Cortex Soleus muscle; Extensor digitorum longus muscle; Myotonic depres 5-HT (5-hydroxytryptamine, serotonin); NMDA (N-methyl-D-aspar- sion (Liu, S.-H. (231) 23) tate); Transmitter interaction (Rahman, S. (231) 347) 496 Corticosterone DOI (1-(2,5-dimethoxy-4-iodopheny!)-2-aminopropane) Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodopheny! )-2-aminopropane ) Ipsapirone; 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Glucose 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Glucose; Prolactin; Corticosterone; Prolactin; Behaviour (Baudrie, V. (231) 395) Behaviour (Baudrie, V. (231) 395) Dopamine Coupling mechanism Dystonia; Phenobarbital; GABA (y-aminobutyric acid); Glutamate GABA, receptors; Hippocampus (Potier, B. (231) 427) Haloperidol (Richter, A. (231) 111) CP-96,345 Microdialysis; Ethanol reinforcement; Tolerance (Rossetti, Z.L. (231) on Allergen; Bradykinin; Airway microvascular leakage; NK, receptors; 203) Substance P (Sakamoto, T. (231) 31) oa Receptor ligands; Microdialysis; Vacuous chewing; DTG (1,3-di CPPene (D(—)-(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-car o-tolylguanidine); (+ )-Pentazocine (Patrick, $.L. (231) 243) boxylic acid) DBA/2 mice; Aniracetam; AMPA receptor antagonists; NBOX Dopamine neurons (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo( F )quinoxaline); GYKI 52466 Reserpine; Substantia nigra pars compacta; Dopamine receptor ago (1-44-aminopheny])-4-methyl-7,8-methylenedioxy-5H-2,3-benzodi- nists; Firing pattern; Single-unit recording; Supersensitivity (Sun, azepine -H Cl) (Chapman, A.G. (231) 301) B.-C. (231) 331) Cromakalim Dopamine receptor agonists Na*.K* ATPase pump; K* channels; Smooth muscle (vascular) Reserpine; Substantia nigra pars compacta; Dopamine neurons; Fir (Hong, K.W. (231) 1) ing pattern; Single-unit recording; Supersensitivity (Sun, B.-C. (231) 331) KRN2391; Heart (isolated, rat); Myocardial ischemia; Energy metabolism (Ohta, H. (231) 323) Dopamine receptors Stereotypies; Behavioral supersensitivity; Autoradiography (Marin, D-Cycloserine C. (231) 191) Aging; NMDA receptors; Glycine; Noradrenaline release; Glycine uptake (Pittaluga, A. (231) 129) Dopamine D, receptors Paw test; SCH 39166; Raclopride; Haloperidol; Dopamine D, recep DADLE (({D-Ala*,D-Leu*]enkephalin) tors (Prinssen, E.P.M. (231) 275) Tolerance; Opioid receptors; Autoradiography; (Rat) (Tao, P.-l (231) 145) Dopamine D, receptors Paw test; SCH 39166; Raclopride; Haloperidol; Dopamine D, recep DBA/2 mice tors (Prinssen, E.P.M. (231) 275) Aniracetam; AMPA receptor antagonists; NBOX (2,3-dihydroxy-6 nitro-7-sulfamoylbenzo(F )quinoxaline); GYKI 52466 (1-(4 Dopamine release aminopheny])-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine MK-801; Ketamine; Methamphetamine; Ceruletide; Cholecys HCl); CPPene (D(— )-(E)-4-(3-phosphonoprop-2-enyl) piperazine-2 tokinin-like decapeptide; Avoidance behaviour (Kuribara, H. (231) 7) carboxylic acid) (Chapman, A.G. (231) 301) DPI 201-106 Dentate gyrus BDF 9148; Positive inotropy; (Enantiomers) (Hoey, A. (231) 477) Field potentials; Long-term potentiation; NMDA receptors; Dex tromethorphan; Methadone; Codeine; Normethadone; MK 801 DTG (1,3-di-o-tolylguanidine) (Krug, M. (231) 355) o Receptor ligands; Dopamine; Microdialysis; Vacuous chewing; (+ )-Pentazocine (Patrick, $.L. (231) 243) 2-Deoxyglucose Somatostatin; Cerebral cortex; Hippocampus; Acetylcholine; Acetyl Duodenum choline receptors (Shibata, S. (231) 381) Neuropeptide Y (NPY); 2 Receptors; CCK (cholecystokinin); Bicar- bonate secretion; (Rat) (Pascaud, X.B. (231) 389) Desipramine Imipramine; Norepinephrine; 5-HT (5-hydroxytryptamine, serotonin); Duodenum (rat) Triiodothyronine (Suzuki, S. (231) 297) Nitric oxide (NO); NO synthase inhibitors; L-NAME (N°-nitro-l arginine methyl ester); HCO, secretion (Takeuchi, K. (231) 135) Dextromethorphan Dentate gyrus; Field potentials; Long-term potentiation; NMDA DuPont Merck S-7389-4 receptors; Methadone; Codeine; Normethadone; MK 801 (Krug, M U-50,488H; Rimcazole; x-Opioid agonists; a Receptor antagonists; (231) 355) EEG power spectra (Young, G.A. (231) 473) Dihydropyridine binding site Dynorphin $312; Dihydrothienopyridine; Aorta (rat); Cerebral microvessels (rat); «-Opioid receptors; Bremazocine; Ileum (guinea-pig) (Webster, J.1 Phenylalkylamine binding site (Dessy, C. (231) 435) (231) 251) Dihydrothienopyridine Dystonia $312; Aorta (rat); Cerebral microvessels (rat); Dihydropyridine bind- Phenobarbital; Dopamine; GABA (y-aminobutyric acid); Glutamate; ing site; Phenylalkylamine binding site (Dessy, C. (231) 435) Haloperidol (Richter, A. (231) 111) Glutamate; Probenecid (Richter, A. (231) 287) Ethanol reinforcement Dopamine; Microdialysis; Tolerance (Rossetti, Z.L. (231) 203) EDRF (endothelium-derived relaxing factor) Renal arteries; Ischemia; Renal hemodynamics; (Rabbit) (Pruneau, ET, receptor antagonists D. (231) 215) Smooth muscle (vascular); Endothelium (vascular); EDRF (endo thelium-derived relaxing factor), Endothelins; ET, receptors; IRI Smooth muscle (vascular); Endothelium (vascular); Endothelins; ET, 1038; Aorta (rat) (Karaki, H. (231) 371) receptors; ET, receptor antagonists; IRL 1038; Aorta (rat) (Karaki H. (231) 371) ET, receptors Smooth muscle (vascular); Endothelium (vascular); EDRF (endo EEG power spectra thelium-derived relaxing factor), Endothelins; ET, receptor antago U-50,488H; Rimcazole; DuPont Merck S-7389-4; «-Opioid agonists nists; IRL 1038; Aorta (rat) (Karaki, H. (231) 371) o Receptor antagonists (Young, G.A. (231) 473) Excitatory amino acids Eformoterol Acamprosate (calciumacetylhomotaurinate); GABA (y-aminobutyric Eosinophils; Respiratory burst; Salmeterol; Salbutamol; B-Adreno acid), Neocortex; Postsynaptic potentials; Neurotransmission (Zeise, M.L. (231) 47) ceptors (Rabe, K.F. (231) 305) Extensor digitorum longus muscle Electrical field stimulation Chlorpromazine; Soleus muscle; Myotonic depression (Liu, S.-H VIP (vasoactive intestinal polypeptide); Nitric oxide (NO); Choliner (231) 23) gic neurotransmission; Inhibitory non-adrenergic non-cholinergic (i NANC) (Belvisi, M.G. (231) 97) Field potentials Dentate gyrus; Long-term potentiation; NMDA receptors; Dex 5-HT (5-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta tromethorphan; Methadone; Codeine; Normethadone; MK 801 mine; Bronchi (rat); 5-HT, receptors; Ketanserin; Mianserin; Spiper (Krug, M. (231) 355) one; Cholinergic nerves (Szarek, J.L. (231) 339) Firing pattern Electrophysiology Reserpine; Substantia nigra pars compacta; Dopamine neurons; Taurine; Ca** channels (L-type); Ca channels (T-type); Cardiac Dopamine receptor agonists; Single-unit recording; Supersensitivity myocytes; Heart cells (embryonic chick); Voltage clamp (whole cell) (Sun, B.-C. (231) 331) (Satoh, H. (231) 443) Food intake Endothelin Nitric oxide (NO); Morphine-induced locomotion; Morphine Endothelin-converting enzyme; Big endothelin-1; Big endothelin-3 (Calignano, A. (231) 415) Phosphoramidon; Hemodynamics; (Rat) (Pollock, D.M. (231) 459) Funnel web spider toxin Endothelin-converting enzyme w-Conotoxin GVIA; Ca channels (voltage-sensitive); Hololena Big endothelin-1; Big endothelin-3; Phosphoramidon; Endothelin curta venom; Neurotransmitter release; Autonomic nerves (Lundy Hemodynamics; (Rat) (Pollock, D.M. (231) 459) P.M. (231) 197) Endothelins GABA (y-aminobutyric acid) Smooth muscle (vascular); Endothelium (vascular); EDRF (endo Acamprosate (calciumacetylhomotaurinate), Excitatory amino acids thelium-derived relaxing factor); ET, receptors; ET, receptor an Neocortex; Postsynaptic potentials; Neurotransmission (Zeise, M.I tagonists; IRL 1038; Aorta (rat) (Karaki, H. (231) 371) (231) 47) Endothelium (vascular) Dystonia; Phenobarbital; Dopamine; Glutamate; Haloperidol (Rich- ter, A. (231) 111) Smooth muscle (vascular); EDRF (endothelium-derived relaxing fac tor); Endothelins; ET, receptors; ET, receptor antagonists; IRI GABA , receptors 1038; Aorta (rat) (Karaki, H. (231) 371) Hippocampus; Coupling mechanism (Potier, B. (231) 427) Energy metabolism Gallopamil KRN2391; Cromakalim; Heart (isolated, rat); Myocardial ischemia Ventricular arrhythmia; (Triggered activity); (Plasma concentration) (Ohta, H. (231) 323) (Matsuzaki, T. (231) 363) (D-Pen?,L-Pen* Jenkephalin Glibenclamide Cocaine; Naltrindole (Ukai, M. (231) 143) Adenosine; Adenosine A, receptor-mediated vasodilatation; K” channels (ATP-sensitive), 8-Phenyltheophylline (Orito, K. (231) 183) Eosinophils Respiratory burst; Salmeterol; Eformoterol; Salbutamol; B-Adreno Glucose ceptors (Rabe, K.F. (231) 305) Ipsapirone; DOI (1-2,5-dimethoxy-4-iodophenyl)-2-aminopropane), 5-HT,, receptors; 5-HT, receptors; Anxiolysis; Corticosterone; Pro- EPA-E (ethyl all-cis-5,8,11,14,17-icosapentaenoate ) lactin; Behaviour (Baudrie, V. (231) 395) Cholesterol metabolism; (Rat) (Mizuguchi, K. (231) 121) Glutamate Ethanol Dystonia; Phenobarbital; Dopamine; GABA (y-aminobutyric acid), (+ )-MK-801; Tolerance; (Rat) (Wu, P.H. (231) 157) Haloperidol (Richter, A. (231) 111) 498 Dystonia; Probenecid (Richter, A. (231) 287) Achatin-l; D-Amino acid residue; Molluscan peptide; Modulatory effects; Voltage clamp; Neurons; (Snail) (Jun Liu, G. (231) 259) Glycine Aging; NMDA receptors; D-Cycloserine; Noradrenaline release; Contractions; Lipoxygenase products; Atherosclerosis; Blood vessels; Glycine uptake (Pittaluga, A. (231) 129) (Interaction) (Van Diest, M.J. (231) 267) Glycine uptake Imipramine; Desipramine; Norepinephrine; Triiodothyronine (Suzu- Aging; NMDA receptors; Glycine; D-Cycloserine; Noradrenaline ki, S. (231) 297) release (Pittaluga, A. (231) 129) a-Methyl-5-hydroxytryptamine; Bronchi (rat); 5-HT, receptors; Ke- Gonadotrophin tanserin; Mianserin; Spiperone; Electrical field stimulation; Cholin- Inhibin; Oestradiol-178; Ovarian hormones; Prostaglandin F,,; In- ergic nerves (Szarek, J.L. (231) 339) domethacin (Kogo, H. (231) 481) NMDA (N-methyl-D-aspartate); Cortex; Transmitter interaction GYKI 52466 (1-(4-aminophenyl)-4-methy!-7,8-methylenedioxy-5H- (Rahman, S. (231) 347) 2,3-benzodiazepine - HCI) DBA/2 mice; Aniracetam; AMPA receptor antagonists; NBQX Vascular 5-HT,-like receptors; 5-Carboxamidotryptamine; (Effect of (2,3-dihydroxy-6-nitro-7-sulfamoy)qlubineonxzaloi(neF) ; CPPene pre-contraction) (Choppin, A. (231) 469) (D( — )-(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid) 5-HT motor syndrome (Chapman, A.G. (231) 301) 5-HT |, receptor agonists; 5-HT,, receptor antagonists; 8-OH-DPAT derivatives; (S)-UH-301; LY-41 (Yu, H. (231) 69) Haloperidol Dystonia; Phenobarbital; Dopamine; GABA (y-aminobutyric acid); 5-HT,, receptor agonists Glutamate (Richter, A. (231) 111) 5-HT,, receptor antagonists; 8-OH-DPAT derivatives; (S)-UH-301; LY-41; 5-HT motor syndrome (Yu, H. (231) 69) Paw test; SCH 39166; Raclopride; Dopamine D, receptors; Dopamine D, receptors (Prinssen, E.P.M. (231) 275) -HT,, receptor antagonists -HT,, receptor agonists; 8-OH-DPAT derivatives; (S)-UH-301; LY- o Receptor ligands; Neurogenic twitch contraction; Benzomorphan- 1; 5-HT motor syndrome (Yu, H. (231) 69) type o receptor; ATP transmission; Vas deferens (mouse); Brain (guinea-pig); SK&F 10,047 (N-allylnormetazocine); Rimcazole 5-HT,, receptors (Matsuno, K. (231) 451) Antidepressants; 5-HT (5-hydroxytryptamine, serotonin); 5-HT,,. re- ceptors; (Rat) (Jenck, F. (231) 223) HCO, secretion Nitric oxide (NO); NO synthase inhibitors; L-NAME (N°-nitro-L- Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodopheny!)-2-aminopropane), arginine methyl ester); Duodenum (rat) (Takeuchi, K. (231) 135) 5-HT, receptors; Anxiolysis; Glucose; Corticosterone; Prolactin; Be- haviour (Baudrie, V. (231) 395) Heart cells (embryonic chick) Taurine; Ca?* channels (L-type); Ca?* channels (T-type); Cardiac 5-HT,, /5-HT, receptors myocytes; Voltage clamp (whole cell); Electrophysiology (Satoh, H. Tryptophan; Blood-brain barrier; Sympathetic nervous system; Im- (231) 443) mobilization stress (Chaouloff, F. (231) 77) Heart (dog) 5-HT,< receptors BRL 37344; B,-Adrenoceptors; Chronotropism; Inotropism (Taka- Antidepressants; 5-HT (5-hydroxytryptamine, serotonin); 5-HT,, re- yama, S. (231) 315) ceptors; (Rat) (Jenck, F. (231) 223) Heart (isolated, rat) 5-HT, receptors KRN2391; Cromakalim; Myocardial ischemia; Energy metabolism 5-HT (S-hydroxytryptamine, serotonin); a-Methyl-5-hydroxytrypta- (Ohta, H. (231) 323) mine; Bronchi (rat); Ketanserin; Mianserin; Spiperone; Electrical field stimulation; Cholinergic nerves (Szarek, J.L. (231) 339) Hemodynamics Endothelin-converting enzyme; Big endothelin-1; Big endothelin-3; Ipsapirone; DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); Phosphoramidon; Endothelin; (Rat) (Pollock, D.M. (231) 459) 5-HT,, receptors; Anxiolysis; Glucose; Corticosterone; Prolactin; Behaviour (Baudrie, V. (231) 395) Hippocampus Somatostatin; 2-Deoxyglucose; Cerebral cortex; Acetylcholine; 5-HT uptake sites Acetylcholine receptors (Shibata, S. (231) 381) Spontaneously hypertensive rat (SHR); Imipramine; Clonidine; Cen- thaquin; Blood pressure; Central nervous system (CNS) (Gulati, A GABA , receptors; Coupling mechanism (Potier, B. (231) 427) (231) 151) Hololena curta venom lleum (guinea-pig) w-Conotoxin GVIA; Ca** channels (voltage-sensitive); Funnel web «x-Opioid receptors; Bremazocine; Dynorphin (Webster, J.L. (231) spider toxin; Neurotransmitter release; Autonomic nerves (Lundy, 251) P.M. (231) 197) Imipramine 5-HT (5-hydroxytryptamine, serotonin) Spontaneously hypertensive rat (SHR); Clonidine; Centhaquin; Blood Antidepressants; 5-HT,<. receptors; 5-HT,, receptors; (Rat) (Jenck, pressure; Central nervous system (CNS); 5-HT uptake sites (Gulati, F. (231) 223) A. (231) 151)

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users